<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Leprosy - QuizMaster Pro</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}


    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / qBank / Dermatology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">43</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 16919,
    "choices": [
      {
        "id": 67636,
        "text": "<p><span style=\"font-size:12.0pt;\">Facial Nerve</span></p>"
      },
      {
        "id": 67637,
        "text": "<p><span style=\"font-size:12.0pt;\">Trigeminal Nerve</span></p>"
      },
      {
        "id": 67638,
        "text": "<p><span style=\"font-size:12.0pt;\">Abducens Nerve</span></p>"
      },
      {
        "id": 67639,
        "text": "<p><span style=\"font-size:12.0pt;\">Optic Nerve</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presents with a BT Leprosy Lesion on the Face as shown in the image below. Which of the following Nerves is most commonly involved in this condition?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/1.jpg\" alt=\"\" width=\"300\" height=\"351\"></span></p>",
    "unique_key": "Q2296465",
    "question_audio": null,
    "question_video": null,
    "map_id": 16480,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A) Facial Nerve</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;</strong>The clinical presentation strongly suggests a <strong>case of leprosy</strong>, with the <strong>facial nerve being the most commonly affected cranial nerve</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Leprosy&nbsp;</strong>is a <strong>chronic granulomatous disease</strong> caused by <strong>Mycobacterium leprae</strong>, which impacts the <strong>mucous membranes</strong>, <strong>cutaneous tissues</strong>, and <strong>peripheral nerves </strong>leading to <strong>sensory and motor deficits</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Most commonly affected nerves:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Peripheral nerves</strong> - <strong>Ulnar</strong> &gt; <strong>Posterior tibial nerve</strong>, median, and lateral popliteal nerves.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Cranial nerves: Facial nerve &gt; Trigeminal nerve.</strong></span></p><ul style=\"list-style-type:circle;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Notably, <strong>facial skin lesions</strong> are associated with a <strong>10-fold increase</strong> in the risk of <strong>facial nerve</strong> involvement in <strong>leprosy cases</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Facial nerve</strong> involvement can lead to facial muscle <strong>weakness, paralysis</strong>, and <strong>loss of facial expressions</strong>, which are characteristic features of this condition.</span></p></li></ul></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>Trigeminal nerve:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The trigeminal nerve (<strong>fifth cranial nerve</strong>) primarily innervates the <strong>face</strong> and is responsible for sensations such as <strong>touch and pain.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">While it can be <strong>affected</strong> in <strong>leprosy,</strong> it is <strong>not the most commonly</strong> involved nerve in BT leprosy lesions on the face.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>Abducens nerve:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>abducens nerve (sixth cranial nerve)</strong> controls the movement of the <strong>lateral rectus muscle</strong> of the eye.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In leprosy, it is less commonly involved compared to the facial nerve, especially in BT leprosy.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>Optic nerve:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The optic nerve (<strong>second cranial nerve</strong>) is responsible for <strong>vision</strong> and is <strong>not commonly</strong> affected in leprosy lesions on the face.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In <strong>patients presenting with</strong> leprosy lesions on the face, the most commonly involved nerve is the <strong>facial</strong> nerve.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref:&nbsp;</u>Rook's Textbook of Dermatology, 9th Edition, Chapter 28, Page No 28.1, 28.3, 28.12</strong></span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Harrison\u2019s Principles of Internal Medicine 20<sup>th</sup> Edition Page No 1385, 1386, 1388</strong></span></p>",
    "correct_choice_id": 67636,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 16920,
    "choices": [
      {
        "id": 67640,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Borderline Tuberculoid is the most common type of Leprosy in India</span></span></span></p>"
      },
      {
        "id": 67641,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Borderline Borderline is the most unstable form of Leprosy</span></span></span></p>"
      },
      {
        "id": 67642,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Earliest Sign of Leprosy is Loss of Temperature</span></span></span></p>"
      },
      {
        "id": 67643,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Facial Nerve is the most common nerve involved in Leprosy</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are correct statements regarding leprosy EXCEPT</span></span></p>",
    "unique_key": "Q2761729",
    "question_audio": null,
    "question_video": null,
    "map_id": 16481,
    "difficulty_level": "difficult",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) Facial&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nerve is the most common nerve involved in Leprosy</span></strong><strong><span style=\"font-size:12.0pt\">.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulnar nerve&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the <strong>most commonly</strong> affected nerve in leprosy.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nerve&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">involvement in<strong> leprosy</strong></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:96px; text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ulnar </span></strong><span style=\"font-size:12.0pt\">&gt; Posterior tibial &gt; Median &gt; Lateral popliteal &gt; Facial</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Borderline Tuberculoid</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is the most common type of leprosy in India.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline Tuberculoid presents as a <strong>hypopigmented</strong> skin lesion with <strong>pseudopodia </strong>&amp; <strong>satellite lesions</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/2.jpg\" style=\"height:494px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spectrum&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">of leprosy in India in <strong>decreasing</strong> order of <strong>prevalence.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:96px; text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Borderline Tuberculoid </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&gt; <strong>Borderline Lepromatous </strong>&gt; Lepromatous Leprosy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Borderline Borderline</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is the most unstable form of leprosy:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presenting with <strong>punched out</strong> anesthetic lesions, which have <strong>Geographical </strong>or <strong>Map like</strong> appearance. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inverted saucer &amp; <strong>punched out</strong> lesions are characteristic of <strong>Borderline Borderline leprosy.</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is rarely seen as it <strong>rapidly</strong> upgrades <strong>towards tuberculoid</strong> or <strong>downgrades</strong> towards <strong>lepromatous pole</strong>, based on <strong>immune status </strong>of the individual.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/3.jpg\" style=\"height:335px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/picture1_Qrhvqpl.jpg\" style=\"height:316px; width:600px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pure Neuritic&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">leprosy (PNL)is <strong>not</strong> included in the <strong>Ridley Jopling</strong> classification. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mononeuritis&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the most common form of presentation of <strong>PNL.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nerve biopsy&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the <strong>gold standard</strong> method for the diagnosis of <strong>PNL.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Earliest sign&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">of leprosy is <strong>loss of temperature</strong>, seen over he <strong>hands</strong> &amp; <strong>feet</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sensations lost</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> in the following order:</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px; text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Temperature </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&gt; Fine Touch &gt; Pain &gt; Deep Touch or Pressure</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ulnar Nerve</strong> is the <strong>most affected nerve </strong>in<strong> Leprosy</strong>, not the facial nerve. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early signs of leprosy include <strong>Loss of Temperature Sensation, </strong>and<strong> Borderline Borderline Leprosy </strong>is the most<strong> immunologically unstable form</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Journal: </span></strong><a href=\"https://ijdvl.com/current-scenario-of-leprosy-at-tertiary-care-level-hospital-of-rural-central-india/\" style=\"color:#0563c1; text-decoration:underline\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">https://ijdvl.com/current-scenario-of-leprosy-at-tertiary-care-level-hospital-of-rural-central-india/</span></strong></a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318064/\" style=\"color:#0563c1; text-decoration:underline\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318064/</span></strong></a>,&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Harrison&rsquo;s Principles of Internal Medicine &ndash; 19<sup>th</sup> Edition Page 1124,.&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Harrison&rsquo;s Principles of Internal Medicine 20<sup>th</sup> Edition Chapter 174 Leprosy,&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Andrew&rsquo;s Diseases of the Skin: Clinical Dermatology &ndash; 12<sup>th</sup> Edition Page No 336,&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rooks Textbook of Dermatology 9th Edition Page 28.10 &ndash; 28.11</span></strong></span></span></p>",
    "correct_choice_id": 67643,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 35810,
    "choices": [
      {
        "id": 143043,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">No Spontaneous Remission is seen</span></span></p>"
      },
      {
        "id": 143044,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Half of the cases Resolve Spontaneously After Bacilli Exposure</span></span></p>"
      },
      {
        "id": 143045,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Spontaneous Remission is more common in Children than in Adults</span></span></p>"
      },
      {
        "id": 143046,
        "text": "<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indeterminate Leprosy has more Remission than Tuberculoid Leprosy</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which among the following is CORRECT regarding the healing of leprosy if left untreated?</span></span></span></p>",
    "unique_key": "Q3607957",
    "question_audio": null,
    "question_video": null,
    "map_id": 23045,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Indeterminate&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Leprosy has more Remission than Tuberculoid Leprosy.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the given options, <strong>Indeterminate leprosy</strong> has more <strong>remission</strong> than <strong>tuberculoid</strong> is the <strong>most appropriate answer</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The bacillus <strong>Mycobacterium leprae</strong> is the source of the <strong>chronic infectious granulomatous disease</strong> known as <strong>leprosy</strong> <strong>(Hansen&#39;s disease)</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Clinically, leprosy&nbsp;</span></strong><span style=\"font-size:12.0pt\">can exhibit<strong> one </strong>or<strong> more </strong>of the following symptoms</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patches of<strong> hypopigmentation</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Presence of <strong>thickened nerves</strong>, and </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Partial or complete <strong>loss of cutaneous sensation </strong>in the <strong>affected areas</strong> (</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">First sensory modality to be lost is <strong><u>Temperature </u>(hot/cold </strong>differentiation). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of acid-fast bacilli in nasal smears or the skin.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leprosy symptoms vary depending on how an individual&#39;s <strong>immune</strong> system reacts to the <strong>bacillus Mycobacterium leprae</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spontaneous resolution&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">can be seen in about <strong>80&ndash;90% (</strong>NOT just 50% as given in Option B) of people after being exposed to bacteria.&nbsp; The remaining patients get clinical leprosy. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indeterminate leprosy typically has <strong>hypopigmented</strong>, <strong>ill-defined lesions</strong>. 75 percent of those <strong>Indeterminate leprosy</strong> patients <strong>experience spontaneous remission</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinically, very few patients exhibit either <strong>lepromatous</strong> leprosy or <strong>tuberculoid</strong> leprosy. As a result, compared to patients with <strong>tuberculoid leprosy</strong>, more patients with <strong>indeterminate</strong> leprosy experience <strong>spontaneous remission</strong>. (Choice D)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Even in the <strong>absence</strong> of <strong>specific treatment</strong>, a majority <strong>(80-90%)</strong> of patients tend to get <strong>cured spontaneously.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spontaneous remission&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in <strong>children</strong> is <strong>variable </strong>when compared to adults. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spontaneous remission&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">occurs even in the<strong> absence </strong>of<strong> specific treatment </strong>in<strong> majority (almost 80-90%) </strong>of the<strong> patients, </strong>but when<strong> compared </strong>to<strong> adults, </strong></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in <strong>children spontaneous cure</strong> is very much <strong>variable.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If left untreated, Indeterminate&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">leprosy has a <strong>higher rate</strong> of <strong>spontaneous remission</strong> compared to <strong>tuberculoid leprosy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Rook&#39;s Textbook of Dermatology 9th Edition, Page No 28.7</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Parks Textbook of Preventive &amp; Social Medicine 26<sup>th</sup> Edition Pg No. 359</span></strong></span></span></p>",
    "correct_choice_id": 143046,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 35813,
    "choices": [
      {
        "id": 143055,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tuberculoid Leprosy</span></span></span></p>"
      },
      {
        "id": 143056,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lepromatous Leprosy</span></span></span></p>"
      },
      {
        "id": 143057,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mycosis Fungoides</span></span></span></p>"
      },
      {
        "id": 143058,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post Kala-Azar Dermal Leishmaniasis</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a 45-year-old male patient from Bihar with a normo-anesthetic hypopigmented lesion and a history of prolonged fever in childhood, what is the probable clinical diagnosis, considering the absence of thickened nerves?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/4.jpg\" style=\"height:225px; width:300px\" /></span></span></p>",
    "unique_key": "Q1004768",
    "question_audio": null,
    "question_video": null,
    "map_id": 23046,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Post Kala-Azar Dermal Leishmaniasis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The case scenario suggests a diagnosis of <strong>Post-Kala-Azar Dermal Leishmaniasis</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Occurs <strong>1-5 years </strong>after <strong>Kala Azar </strong>in <strong>untreated or incompletely </strong>treated cases. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Manifests as <strong>nodules</strong> over exposed areas <strong>(Face), Hypopigmented </strong>Macules over <strong>Trunk </strong>and Photosensitivity. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The rash is <strong>progressive </strong>over many years and seldom <strong>heals spontaneously</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/5.jpg\" style=\"height:234px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Important differential for PKDL is Lepromatous leprosy:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/screenshot-2024-02-21-174028.jpg\" style=\"height:413px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug of choice for:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kala azar - <strong>Liposomal Amphotericin B</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PKDL - <strong>Miltefosine</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Tuberculoid leprosy</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This form of leprosy presents with <strong>hypopigmented patches</strong> with <strong>well-defined borders</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">However, it is typically associated with <strong>thickened nerves</strong>, which is <strong>absent</strong> in the patient described.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Lepromatous leprosy</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a more advanced and <strong>disseminated </strong>form of l<strong>eprosy</strong> with <strong>multiple nodules, plaques, and thickened nerves</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It doesn&#39;t fit the presentation described.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Mycosis fungoides</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a type of <strong>cutaneous T-cell lymphoma</strong>. The initial presentation can be <strong>patches</strong>, which might <strong>resemble</strong> the described lesions, but the <strong>history</strong> of <strong>prolonged</strong> <strong>fever </strong>in childhood and the <strong>geographic location (Bihar</strong>) make <strong>PKDL </strong>more <strong>probable</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>PKDL i</strong>s a <strong>probable diagnosis</strong> in a patient with a history of <strong>prolonged fever </strong>in <strong>childhood</strong> presenting with <strong>normo-anesthetic </strong><strong>hypopigmented lesions</strong> without any thickened nerves, especially from the <strong>Bihar</strong> region.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Rooks Textbook of Dermatology- 9<sup>th</sup> Edition Chapter 33 Page No 33.50-33.51, 140.10</span></strong></span></span></p>",
    "correct_choice_id": 143058,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 35815,
    "choices": [
      {
        "id": 143063,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Borderline Tuberculoid Leprosy</span></span></span></p>"
      },
      {
        "id": 143064,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lepromatous Leprosy</span></span></span></p>"
      },
      {
        "id": 143065,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Borderline Leprosy</span></span></span></p>"
      },
      {
        "id": 143066,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histoid Leprosy</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Below-Given Image is characteristically seen in which of the following type of Leprosy?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/3_f3Flb2X.jpg\" style=\"height:201px; width:300px\" /></span></span></p>",
    "unique_key": "Q1529462",
    "question_audio": null,
    "question_video": null,
    "map_id": 23047,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C) Borderline Leprosy (BB Leprosy)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><strong><span style=\"font-size:12.0pt\"> C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given image shows a case of <strong>borderline leprosy, </strong>or<strong> dimorphous</strong> leprosy, as evidenced by the <strong>inverted saucer</strong> <strong>shaped</strong> cutaneous lesions on the patient&#39;s skin. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inverted saucer</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> shaped <strong>cutaneous lesions</strong> can also be seen in <strong>Borderline Lepromatous Leprosy (BL).</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A</span></strong><span style=\"font-size:12.0pt\">. Borderline Tuberculoid Leprosy </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by <strong>fewer</strong> and more <strong>well-demarcated lesions</strong> than <strong>borderline leprosy</strong>, and there is a finding called as <strong>Satellite lesions</strong> which can be seen in <strong>BT leprosy</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">. Lepromatous leprosy </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It presents with <strong>numerous lesions</strong> that are <strong>more symmetrical</strong> and have <strong>less sensory loss</strong>; it represents <strong>one polar end</strong> of the <strong>leprosy spectrum</strong> with a <strong>high bacterial load</strong></span><strong>.</strong> </span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. Histoid leprosy </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a <strong>rare form</strong> of <strong>lepromatous leprosy</strong> presenting with <strong>firm</strong>, <strong>nodular lesions</strong> that typically do not resemble the &quot;inverted saucer&quot; appearance.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation of <strong>borderline leprosy</strong> (<strong>BB Leprosy</strong>) and distinguish it from other forms of <strong>leprosy</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It highlights the importance of <strong>recognizing</strong> the <strong>characteristic</strong> &quot;<strong>inverted saucer</strong>&quot; <strong>appearance</strong> of the <strong>cutaneous lesions</strong> and understanding the <strong>spectrum</strong> of <strong>leprosy classifications</strong>, which is essential for <strong>appropriate diagnosis</strong> and<strong> management</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Rooks Textbook of Dermatology 9<sup>th</sup> Edition Page No 28.3, 28.5, 28.10</span></strong></span></span></p>",
    "correct_choice_id": 143065,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 35817,
    "choices": [
      {
        "id": 143071,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Median Nerve</span></span></span></p>"
      },
      {
        "id": 143072,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Superficial Branch of Radial Nerve</span></span></span></p>"
      },
      {
        "id": 143073,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ulnar Nerve</span></span></span></p>"
      },
      {
        "id": 143074,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lateral Popliteal Nerve</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which nerve is biopsied for the diagnosis of Pure Neuritic leprosy?</span></span></span></p>",
    "unique_key": "Q7053992",
    "question_audio": null,
    "question_video": null,
    "map_id": 23048,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Superficial Branch of Radial Nerve.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Superficial branch of radial nerve<strong> </strong></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is <strong>most commonly</strong> used for <strong>nerve</strong> <strong>biopsy</strong> in <strong>pure neuritic leprosy.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pure neuritic leprosy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is characterized by <strong>asymmetrical involvement</strong> of <strong>peripheral </strong>nerve trunks <strong>without visible skin lesions</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To confirm the diagnosis of pure neuritic leprosy, nerve biopsy is considered the <strong>gold standard.</strong> It is essential to biopsy <strong>only sensory nerves</strong> and avoid motor or major nerve trunks, as well as mixed nerves.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For <strong>nerve biopsy</strong> in <strong>neuritic leprosy</strong>, the <strong>superficial sensory branch </strong>of the<strong> radial nerve</strong> is typically utilized.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/7.jpg\" style=\"height:203px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The biopsy sample should be taken from a <strong>purely sensory thickened</strong> <strong>peripheral nerve</strong>, such as the <strong>superficial sensory branch </strong>of the<strong> radial nerve</strong> at the <strong>wrist</strong>, <strong>ulnar cutaneous nerve </strong>near the<strong> ulnar border </strong>of the<strong> base </strong>of the<strong> hand</strong>, or <strong>sural nerve</strong> <strong>near</strong> the <strong>ankle</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For the diagnosis of <strong>Pure Neuritic Leprosy</strong>, the <strong>superficial branch of the radial</strong> nerve is the preferred site for biopsy due to its <strong>accessibility, lower risk of complications, and high diagnostic yield.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Rook&#39;s Textbook of Dermatology -9th Edition Chapter 28 Page No 28.11 28.14,&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sensory reanimation of the hand by transfer of the superficial branch of the radial nerve to the median and ulnar nerve - Scientific Figure on ResearchGate. Available from: https://www.researchgate.net/figure/Transfer-of-the-superficial-branch-of-the-radial-nerve-SBRN-to-the-median-nerve-MN_fig5_309138539 [accessed 9 Nov, 2023] </span></strong></span></span></p>",
    "correct_choice_id": 143072,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 35818,
    "choices": [
      {
        "id": 143075,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Mycobacterium Tuberculosis </span></span></span></p>"
      },
      {
        "id": 143076,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Mycobacterium Leprae </span></span></span></p>"
      },
      {
        "id": 143077,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Mycobacterium Marinum </span></span></span></p>"
      },
      {
        "id": 143078,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Onchocerca Volvulus</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented with Incomplete Closure of Left Eye. On examination Orbicularis Oculi weakness was found, and Cornea shows Decreased Sensation. Which of the following organisms is most likely associated with these findings? </span></span></p>",
    "unique_key": "Q5626125",
    "question_audio": null,
    "question_video": null,
    "map_id": 23049,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>B) Mycobacterium Leprae</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leprosy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, also known as <strong>Hansen&#39;s disease</strong>, is caused by <strong>Mycobacterium leprae</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It affects the <strong>skin, peripheral </strong>and<strong> cranial nerves</strong>, leading to findings such as <strong>Orbicularis Oculi Weakness (Lagophthalmos)</strong> and <strong>Decreased Corneal Sensation.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Mycobacterium tuberculosis</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mycobacterium tuberculosis is the causative agent of <strong>tuberculosis</strong>, not typically associated with nerve involvement that would lead to <strong>orbicularis oculi weakness</strong> or <strong>corneal anaesthesia</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Mycobacterium marinum</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mycobacterium marinum causes a <strong>skin disease</strong> known as <strong>&quot;aquarium granuloma</strong>,&quot; which typically does not lead to the neural or ocular symptoms described.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Onchocerca volvulus</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Onchocerca volvulus is a <strong>parasitic worm</strong> that causes <strong>onchocerciasis</strong>, also known as <strong>river blindness</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is associated with <strong>severe itching, visual impairment </strong>and<strong> permanent blindness.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mycobacterium leprae</strong>&nbsp;is the causative organism of <strong>leprosy (Hansen&#39;s disease</strong>), which can lead to <strong>nerve involvement</strong> manifesting as <strong>orbicularis oculi weakness</strong> and <strong>decreased corneal sensation</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 27 Page No 378</span></strong></span></span></p>",
    "correct_choice_id": 143076,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 35821,
    "choices": [
      {
        "id": 143087,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-d, 2-a, 3-b, 4-c</span></span></span></p>"
      },
      {
        "id": 143088,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-c, 2-a, 3-b, 4-d</span></span></span></p>"
      },
      {
        "id": 143089,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-c, 2-a, 3-d, 4-b</span></span></span></p>"
      },
      {
        "id": 143090,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-a, 2-c, 3-b, 4-d</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Match the following Leprosy types in Column A with their clinical features in Column B:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/screenshot-2024-02-21-174804.jpg\" style=\"height:209px; width:1000px\" /></span></span></span></p>",
    "unique_key": "Q5673089",
    "question_audio": null,
    "question_video": null,
    "map_id": 23050,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 1-c, 2-a, 3-b, 4-d</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/screenshot-2024-02-21-174818.jpg\" style=\"height:244px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Option 1. Indeterminate leprosy (IL) (c No Nerve Involvement)</span></strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indeterminate leprosy is an early form of the disease and often presents with <strong>nonspecific skin lesions without</strong> definite <strong>nerve </strong>involvement.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">2. Lepromatous Leprosy (LL) (a Leonine Facies)</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepromatous leprosy is characterized by <strong>diffuse infiltration of the skin</strong>, which can lead to <strong>thickening of the skin</strong> and the classic <strong>leonine facies (lion-like</strong> appearance).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">3. Borderline Borderline (BB) (b Punched Out Lesions)</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Punched out lesions with <strong>well-defined inner border </strong>and<strong> ill-defined outer border</strong> can be seen in BB hansens disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/8.jpg\" style=\"height:434px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">4. Tuberculoid (TT) (d Saucer right way up lesions)</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberculoid leprosy presents with <strong>well-demarcated</strong>, <strong>hypopigmented</strong>, and <strong>anesthetic skin lesions</strong> which have <strong>well defined border</strong> and the <strong>elevated border slopes down</strong> to <strong>flat centre</strong>, which is described as &ldquo;<strong>Saucer right way up</strong>&rdquo; <strong>lesion</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical features associated with different types of leprosy: <strong>indeterminate</strong> leprosy presents <strong>without nerve</strong> involvement, <strong>lepromatous</strong> leprosy can present with <strong>leonine</strong> facies, and <strong>tuberculoid leprosy</strong> presents with <strong>Saucer right way up</strong> skin lesions.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 15 Page No 240-245</span></strong></span></span></p>",
    "correct_choice_id": 143088,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 35822,
    "choices": [
      {
        "id": 143091,
        "text": "<p><span style=\"font-size:12.0pt;\">Borderline Lepromatous</span></p>"
      },
      {
        "id": 143092,
        "text": "<p><span style=\"font-size:12.0pt;\">Borderline Tuberculoid</span></p>"
      },
      {
        "id": 143093,
        "text": "<p><span style=\"font-size:12.0pt;\">Lepromatous</span></p>"
      },
      {
        "id": 143094,
        "text": "<p><span style=\"font-size:12.0pt;\">Tuberculoid</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 38-years-old male presents with multiple hypopigmented and hypo anaesthetic lesions over his body, which are almost symmetrical. Which of the following leprosy is present in this patient?</span></p>",
    "unique_key": "Q6921356",
    "question_audio": null,
    "question_video": null,
    "map_id": 23051,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A) Borderline Lepromatous</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In borderline lepromatous leprosy, patients typically present with <strong>numerous lesions</strong> that are <strong>almost symmetrically distributed</strong>, as described.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">This form is <strong>between lepromatous</strong> and <strong>tuberculoid</strong> on the <strong>spectrum</strong>, showing features of both.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>Borderline tuberculoid:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In Borderline tuberculoid leprosy, the number of lesions is<strong> fewer</strong> and they are <strong>non-symmetrical</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">There may also be a characteristic <strong>\"satellite lesion</strong>\" near a <strong>larger patch</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>Lepromatous:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Lepromatous Leprosy presents with <strong>diffuse, symmetrical</strong> skin involvement that includes <strong>macules, patches, </strong>and<strong> nodular</strong> <strong>lesions</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The lesions are <strong>more numerous</strong> and <strong>widespread</strong> than in the <strong>borderline forms</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Also, <strong>sensations over lesions</strong> are mostly <strong>intact</strong> in <strong>LL</strong>, as opposed to mentioned in this <strong>clinical vignette</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>Tuberculoid:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Tuberculoid leprosy presents with a <strong>single </strong>or<strong> few well-demarcated</strong>, <strong>hypopigmented,</strong> and <strong>anesthetic patches</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">These lesions have a <strong>\"saucer-shaped\"</strong> <strong>appearance</strong> and represent a <strong>strong immune response</strong> that limits the <strong>number</strong> of <strong>lesions</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The presence of <strong>multiple annular </strong>or<strong> punched-out</strong> lesions with <strong>almost symmetrical distribution</strong> suggests <strong>borderline lepromatous leprosy</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">This form shows features <strong>intermediate</strong> between <strong>lepromatous </strong>and<strong> tuberculoid</strong> leprosy, with a <strong>higher number of lesions </strong>than<strong> borderline</strong> <strong>tuberculoid leprosy</strong> and <strong>less symmetry </strong>than<strong> lepromatous leprosy.</strong>Top of Form</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 15 Page No 244</strong></span></p>",
    "correct_choice_id": 143091,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 35824,
    "choices": [
      {
        "id": 143099,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Borderline Lepromatous (BL)</span></span></span></p>"
      },
      {
        "id": 143100,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lepromatous Leprosy (LL)</span></span></span></p>"
      },
      {
        "id": 143101,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Borderline Tuberculoid (BT)</span></span></span></p>"
      },
      {
        "id": 143102,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline (BB)</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following types of leprosy is most seen India?</span></span></p>",
    "unique_key": "Q1021838",
    "question_audio": null,
    "question_video": null,
    "map_id": 23052,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>C) Borderline Tuberculoid (BT)</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline tuberculoid leprosy is the <strong>most common form</strong> of leprosy in <strong>India</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It typically presents with a <strong>few hypopigmented patches</strong> with a <strong>mildly elevated</strong> <strong>border</strong> and sloping to a <strong>flat centre</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of a <strong>satellite lesion</strong> near a <strong>larger patch</strong> is characteristic of <strong>BT leprosy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Borderline Lepromatous (BL)</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline lepromatous leprosy does occur in India, it is not the most common form.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by <strong>multiple hypopigmented patches</strong> that tend towards <strong>symmetry</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Lepromatous Leprosy (LL)</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepromatous leprosy presents with <strong>numerous diffuse nodules</strong> and <strong>plaques</strong> and tends to have a <strong>symmetric distribution</strong>, but it is not the most common type of leprosy in India.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Borderline (BB)</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline (BB) leprosy represents an <strong>intermediate form </strong>between <strong>tuberculoid</strong> and <strong>lepromatous leprosy</strong> and is less common than BT leprosy. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by <strong>punched-out lesions</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is the <strong>most unstable</strong> form of leprosy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Borderline tuberculoid (BT) leprosy</strong>&nbsp;is the <strong>most common form</strong> of leprosy in <strong>India</strong>, typically presenting with a <strong>single or few hypopigmented</strong> patches with a characteristic <strong>satellite lesion.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 15 Page No 242</span></strong></span></span></p>",
    "correct_choice_id": 143101,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 35826,
    "choices": [
      {
        "id": 143107,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">History of Atopy might be present in the Family</span></span></span></p>"
      },
      {
        "id": 143108,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mostly happens in Children</span></span></span></p>"
      },
      {
        "id": 143109,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Indeterminate Leprosy is an important differential for this presentation</span></span></span></p>"
      },
      {
        "id": 143110,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a Variant of Vitiligo</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old child came with white lesions over his face as shown in the image below. Which of the following statements is INCORRECT regarding this condition?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/9.jpg\" style=\"height:307px; width:300px\" /></span></span></p>",
    "unique_key": "Q3631483",
    "question_audio": null,
    "question_video": null,
    "map_id": 23053,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) It is a Variant of Vitiligo</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the information provided and the appearance of the lesions in the image, the diagnosis is most likely <strong>pityriasis alba</strong>, which is a common skin disorder seen in <strong>children</strong> that causes <strong>hypopigmented, scaly patches. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is incorrect regarding the condition in the image. <strong>Pityriasis alba</strong> is <strong>not</strong> a variant of <strong>vitiligo.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitiligo is characterized by the <strong>complete absence </strong>of <strong>melanocytes</strong> in the <strong>affected area</strong>, leading to <strong>well-demarcated</strong>, <strong>White patches (Depigmented lesions)</strong>, whereas pityriasis alba typically presents with less distinct, more irregular patches that are not completely depigmented.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">History of atopy might be present in the family</span><span style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pityriasis alba&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is often associated with a <strong>history of atopic dermatitis </strong>or other <strong>atopic</strong> diseases, which may have a <strong>familial</strong> occurrence.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">. Mostly happens in children:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pityriasis alba</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> predominantly occurs in <strong>children</strong> and is considered a <strong>benign</strong> condition that usually <strong>resolves with age.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Indeterminate leprosyis an important differential for this presentation:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When evaluating hypopigmented lesions, especially in areas where <strong>leprosy </strong>is<strong> endemic,</strong> it is crucial to consider <strong>leprosy</strong> in the <strong>differential diagnosis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/picture2_MmTcLXW.jpg\" style=\"height:313px; width:500px\" /></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/10.jpg\" style=\"height:583px; width:500px\" /></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indeterminate leprosy&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">presents with a single <strong>hypopigmented macule</strong> and can be a consideration <strong>before</strong> the disease <strong>progresses</strong> to <strong>more definitive forms</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong>Biopsy is the IOC;</strong>&nbsp;Peri-neural, Periappendageal Lymphyocytosis seen.</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pityriasis alba</strong>&nbsp;is a common cause of <strong>hypopigmented lesions</strong> in <strong>children,</strong> which may be confused with other conditions such as <strong>vitiligo</strong> or <strong>indeterminate</strong> leprosy. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the <strong>clinical presentation</strong> and associated conditions, like <strong>atopy,</strong> is essential for <strong>accurate diagnosis</strong> and <strong>appropriate management</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Rook&#39;s Textbook of Dermatology -9th Edition Page No 39.25, 88.34</span></strong></span></span></p>",
    "correct_choice_id": 143110,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 35828,
    "choices": [
      {
        "id": 143115,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Borderline Lepromatous (BL) </span></span></span></p>"
      },
      {
        "id": 143116,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lepromatous Leprosy (LL) </span></span></span></p>"
      },
      {
        "id": 143117,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Borderline Tuberculoid (BT) </span></span></span></p>"
      },
      {
        "id": 143118,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline (BB)</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man from a Leprosy-Endemic Region presents with Painless Ulcers on the soles of his Feet. He has a history of symmetrically distributed Skin Nodules, and on examination, you notice Thickened Peripheral Nerves. The ulcers have a punched-out appearance with a pale base and undermined edges. Which type of leprosy is most commonly associated with these findings?</span></span></p>",
    "unique_key": "Q5913569",
    "question_audio": null,
    "question_video": null,
    "map_id": 23054,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>B) Lepromatous Leprosy (LL)</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepromatous leprosy is characterized by <strong>extensive skin lesions</strong> and <strong>nerve involvement </strong>not due to nerve compression but due to <strong>invasion of the nerves by the bacilli</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nerve invasion occurs in <strong>late stages of LL</strong> and is seen in peripheral nerves (<strong>peripheral neuropathy</strong>).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/11.jpg\" style=\"height:653px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to widespread nerve involvement, there is development of <strong>trophic ulcers</strong>, particularly on pressure points like the feet, due to unnoticed injuries.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Borderline Lepromatous (BL) Leprosy</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a <strong>less severe form</strong> than LL and typically presents with <strong>less extensive skin lesions</strong> and <strong>nerve involvement</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Borderline Tuberculoid (BT) Leprosy </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It presents with skin lesions that are <strong>fewer</strong> in <strong>number</strong> and <strong>more well-demarcated</strong> than <strong>BL</strong> or <strong>LL</strong>, with more significant nerve involvement leading to <strong>anaesthesia</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Borderline (BB) leprosy </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an <strong>intermediate form</strong> and can present with <strong>skin lesions</strong> that have an &quot;<strong>inverted saucer</strong>&quot; <strong>appearance</strong>, but without the extensive nodule formation seen in LL.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lepromatous leprosy (LL)</strong>&nbsp;is the type of leprosy that commonly presents with <strong>trophic ulcers</strong> due to its <strong>extensive nerve damage</strong>, leading to <strong>loss of sensation</strong> and <strong>unrecognized trauma,</strong> particularly in pressure areas like the <strong>soles of the feet.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span></strong><strong><span style=\"font-size:12.0pt\">Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page no 326</span></strong></span></span></p>",
    "correct_choice_id": 143116,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 35830,
    "choices": [
      {
        "id": 143123,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Borderline Lepromatous (BL) </span></span></span></p>"
      },
      {
        "id": 143124,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lepromatous Leprosy (LL) </span></span></span></p>"
      },
      {
        "id": 143125,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pure Neuritic Leprosy </span></span></span></p>"
      },
      {
        "id": 143126,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline (BB)</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following types of leprosy is NOT included in Ridley Jopling Classification?</span></span></p>",
    "unique_key": "Q5050425",
    "question_audio": null,
    "question_video": null,
    "map_id": 23058,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>C) Pure Neuritic Leprosy</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pure Neuritic Leprosy is <strong>not included</strong> in the Ridley-Jopling classification, which classifies leprosy based on the <strong>immunological response</strong> and only includes forms with <strong>cutaneous lesions.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indeterminate leprosy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is also NOT included in this classification system.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Ridley-Jopling Classification</strong> includes: </span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Tuberculoid Leprosy&nbsp;</span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Borderline Tuberculoid</span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Borderline Borderline</span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Borderline Lepromatous </span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Lepromatous Leprosy&nbsp;</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Borderline Lepromatous (BL)</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline lepromatous is a part of the <strong>Ridley-Jopling classification</strong> of <strong>leprosy</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It represents an <strong>immunological form</strong> of <strong>leprosy</strong> that falls <strong>between lepromatous</strong> and <strong>tuberculoid leprosy</strong> on the <strong>spectrum</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Lepromatous Leprosy (LL)</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepromatous leprosy is <strong>one end</strong> of the <strong>spectrum</strong> in the <strong>Ridley-Jopling classification</strong>, characterized by a <strong>large number of bacilli </strong>and<strong> diffuse lesions.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Borderline (BB)</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline (BB) leprosy, also known as <strong>mid-borderline</strong> or <strong>borderline-borderline leprosy</strong>, is included in the <strong>Ridley-Jopling classification</strong> and represents an <strong>intermediate</strong> form <strong>between BL</strong> and <strong>BT leprosy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pure Neuritic Leprosy</strong> is not part of the Ridley-Jopling classification of leprosy, as this classification system is based on the <strong>spectrum of disease</strong> with <strong>cutaneous</strong> lesions and <strong>immunological response</strong>, whereas <strong>Pure Neuritic</strong> Leprosy presents only with <strong>nerve involvement</strong> without the skin lesions typically seen in leprosy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page No 8, 9</span></strong></span></span></p>",
    "correct_choice_id": 143125,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 35833,
    "choices": [
      {
        "id": 143135,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pityriasis Alba </span></span></span></p>"
      },
      {
        "id": 143136,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Indeterminate Leprosy </span></span></span></p>"
      },
      {
        "id": 143137,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atopic Dermatitis </span></span></span></p>"
      },
      {
        "id": 143138,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Niacin Deficiency</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 10-year-old boy from Bihar presents with a 9 Month History of an Ill-Defined, Hypopigmented Slightly Atrophic Patch on the face as shown in the image below. The most likely diagnosis is: </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/12.jpg\" style=\"height:350px; width:300px\" /></span></span></p>",
    "unique_key": "Q6620382",
    "question_audio": null,
    "question_video": null,
    "map_id": 23059,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B) Indeterminate Leprosy</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Indeterminate leprosy presents with a <strong>single, hypopigmented</strong>, slightly <strong>atrophic patch. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sensation</span></strong><span style=\"font-size:12.0pt\"> can be <strong>normal</strong> or <strong>impaired</strong>, and the location of the patient (<strong>Bihar</strong>, a region <strong>endemic</strong> to <strong>leprosy</strong>) supports this diagnosis.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Biopsy is the IOC: </strong>Peri-neural, Periappendageal Lymphyocytosis seen.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Pityriasis alba</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pityriasis alba typically presents as <strong>multiple, ill-defined</strong>, <strong>hypopigmented patches</strong> primarily on the <strong>face </strong>and is often associated with a <strong>history of atopy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/picture2_Di4qnXQ.jpg\" style=\"height:375px; width:600px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lesions are <strong>mildly</strong> <strong>scaly</strong> and <strong>non-atrophic</strong>, and <strong>sensation</strong> is <strong>intact</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Atopic Dermatitis</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atopic dermatitis usually presents with <strong>pruritic, eczematous </strong>lesions, often in <strong>flexural </strong>areas, not typically as a single hypopigmented atrophic patch.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Niacin Deficiency</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Niacin deficiency, or <strong>pellagra,</strong> typically presents with <strong>dermatitis</strong> in <strong>sun-exposed areas</strong>, <strong>diarrhea, </strong>and<strong> dementia</strong>, not as a single hypopigmented atrophic patch on the face.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diagnose <strong>indeterminate leprosy</strong> by identifying a <strong>single</strong>, <strong>hypopigmented</strong>, <strong>slightly atrophic patch</strong> on the <strong>skin</strong>, with possibly <strong>impaired sensation</strong>, especially in a patient from an <strong>endemic area</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-size:12.0pt\">Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page no 16</span></strong></span></span></p>",
    "correct_choice_id": 143136,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 35834,
    "choices": [
      {
        "id": 143139,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diascopy </span></span></span></p>"
      },
      {
        "id": 143140,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lepromin Test </span></span></span></p>"
      },
      {
        "id": 143141,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Slit Skin Smear</span></span></span></p>"
      },
      {
        "id": 143142,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Woods Lamp</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-years-old male presented with multiple hypopigmented macules on trunk. On examination, the lesions were non-scaly, shiny and hypo aesthetic. Which of the following tests should be performed to confirm the diagnosis? </span></span></p>",
    "unique_key": "Q1390697",
    "question_audio": null,
    "question_video": null,
    "map_id": 23060,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Slit Skin Smear</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A slit skin smear is performed by taking a <strong>sample</strong> from the <strong>earlobes</strong> or <strong>lesions</strong> and staining for <strong>acid-fast bacilli</strong>, which is <strong>diagnostic</strong> for <strong>leprosy</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It helps to detect the presence of <strong>Mycobacterium leprae</strong> in the skin lesions.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This clinical vignette is suggestive a<strong> </strong>patient with<strong> Leprosy</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Diascopy</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diascopy is used to determine the nature of <strong>erythema</strong> or lesions by <strong>applying</strong> <strong>pressure </strong>with a <strong>glass slide. </strong></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It helps to <strong>differentiate erythema</strong> from <strong>purpura</strong> but is not useful for diagnosing hypopigmented, anesthetic lesions in leprosy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Lepromin Test</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepromin test is <strong>not a diagnostic</strong> test for leprosy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is used to determine the type of <strong>immune response (cell-mediated</strong> <strong>immunity</strong>) a person has to <strong>Mycobacterium leprae</strong> and can help<strong> classify </strong>the form<strong> of leprosy </strong>and to give estimate of the<strong> prognosis </strong>of the patients<strong>, </strong>but does not confirm the presence of the disease itself.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Woods Lamp</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Woods lamp is used to highlight areas of <strong>skin depigmentation</strong>, such as in <strong>vitiligo</strong> or some <strong>fungal infections. </strong></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is not useful for diagnosing leprosy, as the causative organism does not fluoresce under UV light.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perform a <strong>slit skin smear</strong> to <strong>diagnose leprosy</strong> by detecting <strong>Mycobacterium leprae </strong>in <strong>skin lesions</strong>, particularly when the clinical presentation includes <strong>multiple hypopigmented</strong>, <strong>non-scaly</strong>, <strong>shiny</strong>, and <strong>hypoesthetic macules</strong> on the <strong>trunk</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IAL Textbook of Leprosy, 2<sup>nd</sup> Edition, Page No 278, 299</span></strong></span></span></p>",
    "correct_choice_id": 143141,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 35835,
    "choices": [
      {
        "id": 143143,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Touch</span></span></span></p>"
      },
      {
        "id": 143144,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pain</span></span></span></p>"
      },
      {
        "id": 143145,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hot and Cold Differentiation</span></span></span></p>"
      },
      {
        "id": 143146,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vibration</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following sensations should be checked first in a patient suffering from Leprosy?</span></span></p>",
    "unique_key": "Q5660279",
    "question_audio": null,
    "question_video": null,
    "map_id": 23061,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Hot and Cold Differentiation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In leprosy, the <strong>first sensation</strong> to be <strong>lost</strong> is the ability to <strong>differentiate between hot </strong>and<strong> cold</strong> <strong>temperatures</strong>, which is an <strong>early sign </strong>of<strong> nerve involvement.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sensations lost</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> in the following order:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Temperature (</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hot and Cold differentiation) </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt; <strong>Fine Touch</strong> &gt; <strong>Pain</strong> &gt; <strong>deep touch</strong> or <strong>pressure</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In leprosy, the <strong>differentiation between hot and cold temperatures</strong> is the first sensory modality affected due to nerve involvement. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This <strong>early clinical sign</strong> should be <strong>checked first</strong> in patients suspected of <strong>having leprosy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 11 Page No 175</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 28 Page No 442</span></strong></span></span></p>",
    "correct_choice_id": 143145,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 35836,
    "choices": [
      {
        "id": 143147,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patient is Infective</span></span></span></p>"
      },
      {
        "id": 143148,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lepromin Test is Negative as Cell Mediated Immunity is very Low</span></span></span></p>"
      },
      {
        "id": 143149,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Facial Nerve involvement may lead to Blindness</span></span></span></p>"
      },
      {
        "id": 143150,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaesthetic Skin Patches and Tender Nerves Seen</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following statements are TRUE in relation to Lepromatous Leprosy, EXCEPT?</span></span></p>",
    "unique_key": "Q8907754",
    "question_audio": null,
    "question_video": null,
    "map_id": 23062,
    "difficulty_level": "difficult",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Anaesthetic </span></strong><strong><span style=\"font-size:12.0pt\">Skin Patches and Tender Nerves Seen</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In lepromatous leprosy, patients typically have <strong>extensive skin lesions</strong> with <strong>little </strong>to<strong> no sensation loss (anaesthesia)</strong> and the <strong>nerves are not usually tender</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a feature more characteristic of <strong>tuberculoid leprosy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Patient is infective</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with <strong>lepromatous leprosy</strong> are considered i<strong>nfective</strong> due to the <strong>high bacterial load in their lesions.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Lepromin test is negative as cell mediated immunity is very low</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The lepromin skin test is typically <strong>negative</strong> in lepromatous leprosy because of the <strong>poor cell-mediated immune response</strong> against <strong>Mycobacterium leprae.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Facial nerve involvement may lead to Blindness</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Involvement of the facial nerve can lead to <strong>lagophthalmos </strong>(inability to close the eyelids completely), which can result in <strong>corneal ulcers </strong>and potential <strong>blindness </strong>if not treated.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In lepromatous leprosy, the hallmark features include <strong>extensive non-tender </strong>and<strong> non-anesthetic skin lesions</strong> due to the high number of bacteria and <strong>poor cell-mediated immunity</strong>, which also results in a <strong>negative lepromin test</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Facial nerve </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">involvement can lead to complications such as <strong>blindness</strong>, but tender nerves are not a feature of this type of leprosy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page no 29</span></strong></span></span></p>",
    "correct_choice_id": 143150,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette"
    ]
  },
  {
    "id": 35838,
    "choices": [
      {
        "id": 143155,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ape Thumb Deformity</span></span></span></p>"
      },
      {
        "id": 143156,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Leonine Facies</span></span></span></p>"
      },
      {
        "id": 143157,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Claw Hand</span></span></span></p>"
      },
      {
        "id": 143158,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Foot Drop</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the commonest deformity seen in leprosy?</span></span></p>",
    "unique_key": "Q9665424",
    "question_audio": null,
    "question_video": null,
    "map_id": 23063,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Claw hand</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Claw hand</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Claw hand deformity is the <strong>most common deformity</strong> seen in leprosy. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/13.jpg\" style=\"height:243px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It results from <strong>ulnar nerve damage</strong>, leading to <strong>hyperextension</strong> at the <strong>metacarpophalangeal joints</strong> and <strong>flexion</strong> at the <strong>interphalangeal joints.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Ape thumb deformity</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ape thumb deformity (also known as <strong>simian hand</strong>) can occur in leprosy due to <strong>thenar muscle atrophy</strong>; it is not the most common deformity.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Leonine facies</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leonine facies describes the <strong>facial appearance</strong> often seen in <strong>lepromatous leprosy</strong> due to <strong>infiltrative lesions</strong>, not a deformity of the hands or feet.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/14.jpg\" style=\"height:589px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Foot drop</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Foot drop, resulting from damage to the <strong>common peroneal nerve</strong>, is a common deformity in leprosy but not as frequent as claw hand.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Claw hand deformity</strong>&nbsp;is the <strong>most common</strong> deformity seen in leprosy. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It results from <strong>ulnar nerve damage</strong>, a frequent occurrence in leprosy due to the <strong>bacillus&#39;s affinity</strong> for <strong>cooler temperatures</strong>, where nerves near the skin surface are affected.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page no 331</span></strong></span></span></p>",
    "correct_choice_id": 143157,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 35840,
    "choices": [
      {
        "id": 143163,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It infects Skin, Peripheral Nervous System and Upper Respiratory System</span></span></span></p>"
      },
      {
        "id": 143164,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is transmitted via Respiratory Tract</span></span></span></p>"
      },
      {
        "id": 143165,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It spares CNS, Uterus</span></span></span></p>"
      },
      {
        "id": 143166,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Solid, Fragmented and Granular Bacteria are all viable</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following statements are true related to Mycobacterium leprae EXCEPT?</span></span></p>",
    "unique_key": "Q3608257",
    "question_audio": null,
    "question_video": null,
    "map_id": 23064,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) Solid, Fragmented and Granular Bacteria are all viable</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of leprosy, only the <strong>solid-staining </strong>bacilli are considered <strong>viable</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fragmented and granular</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> forms represent non-viable or <strong>degenerating bacilli</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">It infects skin, peripheral nervous system and upper respiratory system</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mycobacterium leprae targets the <strong>skin, peripheral nerves</strong>, and the mucosa of the <strong>upper respiratory</strong> tract. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It can also infect <strong>Eyes, Testes, Muscles and Bones</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It has a predilection for <strong>cooler areas</strong> of the body.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">It is transmitted via Respiratory tract</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most widely accepted <strong>mode of transmission</strong> for Mycobacterium leprae is via the <strong>respiratory route</strong>, from <strong>nasal</strong> and other secretions of patients with <strong>untreated</strong>, <strong>multibacillary leprosy</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It can also spread through <strong>skin-to-skin contact</strong>, via <strong>trans placental</strong> and through <strong>breast milk.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">It spares CNS, Uterus</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mycobacterium leprae does not typically infect the <strong>central nervous system</strong> or the <strong>uterus</strong>, as the organism prefers <strong>cooler temperatures</strong> than those found in these locations.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">CVS, GIT, Lungs, Prostate, Major blood vessels</span></strong><span style=\"font-size:12.0pt\"> are also spared.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In&nbsp;leprosy, <strong>only solid-staining bacilli</strong> of Mycobacterium leprae are considered <strong>viable</strong>, whereas fragmented and granular forms are not. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recognizing the viability of bacterial forms is essential for understanding the <strong>infectiousness</strong> and <strong>treatment response</strong> of leprosy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 9 Page No 147</span></strong></span></span></p>",
    "correct_choice_id": 143166,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 35842,
    "choices": [
      {
        "id": 143171,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Saucer Right Way up Lesions</span></span></span></p>"
      },
      {
        "id": 143172,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inverted Saucer Shaped Lesions</span></span></span></p>"
      },
      {
        "id": 143173,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Christmas Tree Appearance of Lesions</span></span></span></p>"
      },
      {
        "id": 143174,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dew Drop on Rose Petal Appearance of Lesions</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following options is the classical descriptive term used for the lesions of Borderline Leprosy and also Borderline Lepromatous Leprosy?</span></span></p>",
    "unique_key": "Q5122919",
    "question_audio": null,
    "question_video": null,
    "map_id": 23065,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B) Inverted Saucer Shaped Lesions</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline Leprosy (BB)&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and<strong> Borderline Lepromatous Leprosy (BL)</strong></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are often described as having &quot;<strong>Inverted Saucer Shaped Lesions</strong>.&quot; </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/15.jpg\" style=\"height:334px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This term describes the morphology where the <strong>inner border </strong>of the lesion is <strong>perpendicula</strong>r and <strong>outer margins </strong>are <strong>sloping</strong>, giving an appearance of an inverted saucer.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Saucer right way up lesions</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&quot;Saucer right way up lesions&quot; are seen in <strong>Tuberculoid leprosy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Christmas tree appearance of lesions</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The &quot;<strong>Christmas tree</strong>&quot; <strong>appearance</strong> is not typically used to describe leprosy lesions but is more commonly associated with other dermatological conditions like <strong>pityriasis rosea</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Dew drop on rose petal appearance of lesions</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This description is characteristically used for the vesicles seen in <strong>varicella (chickenpox)</strong>, not leprosy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The&nbsp;<strong>&quot;inverted saucer shaped lesions&quot;</strong>&nbsp;is a descriptive term used for the lesions of <strong>Borderline (BB)</strong> and <strong>Borderline Lepromatous (BL)</strong> Leprosy, indicative of the specific morphological appearance of these lesions in the disease spectrum.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page No 21, 25</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 14 Page No 214</span></strong></span></span></p>",
    "correct_choice_id": 143172,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 16924,
    "choices": [
      {
        "id": 67656,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tuberculoid Leprosy</span></span></span></p>"
      },
      {
        "id": 67657,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lepromatous Leprosy </span></span></span></p>"
      },
      {
        "id": 67658,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Borderline Leprosy</span></span></span></p>"
      },
      {
        "id": 67659,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Borderline Lepromatous leprosy</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histopathology of a tissue sample from a patient with leprosy is shown below. All the following are possibilities EXCEPT.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/1.jpg\" style=\"height:233px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q2362348",
    "question_audio": null,
    "question_video": null,
    "map_id": 16485,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A) Tuberculoid leprosy</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given image shows a <strong>Grenz zone or Band of Unna</strong>, which is a band of uninvolved <strong>papillary dermis </strong>that does not contain granulomas or inflammatory infiltrate. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Grenz zone is absent in <strong>Tuberculoid leprosy</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dermal granulomas</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">, which are collections of <strong>epithelioid cells</strong> with <strong>giant cells</strong>, are seen in <strong>tuberculoid leprosy</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The granulomas are elongated and typically follow <strong>neurovascular bundles</strong>, running <strong>parallel</strong> to the surface. The granulomas extend up to the <strong>epidermis,</strong> thereby obscuring the <strong>Grenz zone.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></u></strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:</span></u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><span style=\"font-size:12.0pt\">Lepromatous Leprosy</span><span style=\"font-size:12.0pt\"> &ndash; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepromatous leprosy represents the <strong>polar opposite</strong> of the leprosy spectrum with <strong>poor cell-mediated immunity</strong> leading to a <strong>multibacillary state</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepromatous leprosy </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">exhibits the Grenz zone most obviously because there are not many <strong>granulomas</strong> to fill the empty spaces below the epidermis.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Virchow cells with globi</strong> as indicated in the image, which are large <strong>macrophages filled with mycobacteria</strong>, are a characteristic feature of <strong>lepromatous leprosy</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additionally, it appears on the <strong>borderline spectrum</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><span style=\"font-size:12.0pt\">Borderline Leprosy</span><span style=\"font-size:12.0pt\"> &ndash;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline leprosy falls within the <strong>middle of the leprosy spectrum</strong>, with histological features that can fluctuate between those seen in tuberculoid and lepromatous forms. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It <strong>can show a grenz zone</strong> and <strong>foamy macrophages,</strong> which makes it a possibility in this case.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><span style=\"font-size:12.0pt\">Borderline Lepromatous leprosy</span><span style=\"font-size:12.0pt\"> &ndash; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline Lepromatous leprosy is a subtype of leprosy that falls between the <strong>lepromatous</strong> <strong>and tuberculoid</strong> forms. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It would show features of both, with <strong>numerous bacteria</strong> present as well as <strong>some immune response</strong> limiting the spread. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therefore, the histological findings seen in the image could correspond to this type, making it a possible option.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>absence</strong> of a <strong>grenz zone</strong> in histopathological samples is associated with <strong>tuberculoid leprosy</strong>, while the <strong>presence</strong> of a <strong>grenz zone</strong> and <strong>Virchow cells </strong>with<strong> globi</strong> are indicative of <strong>lepromatous forms</strong> of the <strong>disease</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></span></u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Rooks Textbook of Dermatology 9<sup>th</sup> Edition Page No. 28.5</span></span></strong></p>",
    "correct_choice_id": 67656,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 16925,
    "choices": [
      {
        "id": 67660,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Multibacillary Leprosy cases need treatment with Multi Drug Therapy (MDT) for 12 Months</span></span></span></p>"
      },
      {
        "id": 67661,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dapsone acts as Anti Leprosy Medication by Inhibiting Folate Synthesis.</span></span></span></p>"
      },
      {
        "id": 67662,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lepromin Testing is used for Diagnosis of Leprosy</span></span></span></p>"
      },
      {
        "id": 67663,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clofazimine causes Deposition of Crystals in Intestinal Mucosa</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All of the following are correct statements regarding management of Leprosy EXCEPT:</span></span></span></p>",
    "unique_key": "Q4916316",
    "question_audio": null,
    "question_video": null,
    "map_id": 16486,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C) Lepromin Testing is used for Diagnosis of Leprosy</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepromin test</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is useful to <strong>classify</strong> the <strong>lesions</strong> of <strong>leprosy patients</strong>, to <strong>assess</strong> the <strong>prognosis </strong><strong>&amp; response to treatment</strong>, to assess the <strong>resistance</strong> of individuals to leprosy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Multibacillary leprosy</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> cases need treatment with Multi Drug Therapy (MDT) for 12 months.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\">Revised Treatment Regimen of Leprosy: </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">Same Drug Dosages and Regimens for both Paucibacillary Leprsoy &amp; Multibacillary Leprosy except Duration ; <strong>Paucibacillary Leprosy for 6 months &amp; Multibacillary Leprosy for 12 months.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/image_NLNztME.png\" style=\"height:262px; width:452px\" /></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dapsone:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapsone (DDS)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> has good<strong> oral absorption</strong>, is weakly bactericidal due to the inhibition of <strong>dihydropteroate synthase</strong>, which <strong>inhibits folate synthesis</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a part of multidrug therapy for leprosy.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adverse effects</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of Dapsone are:</span></span></span></li>\r\n</ul>\r\n\r\n<ol style=\"margin-left:40px\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemolysis &amp; anemia</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Psychosis</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DDS syndrome or 5-week dermatitis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">- occurs <strong>5-6 weeks</strong> after starting dapsone, which presents with:</span></span></span></li>\r\n</ol>\r\n\r\n<ul style=\"margin-left:80px\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erythroderma</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatosplenomegaly</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphadenopathy</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fever</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatitis</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><span style=\"font-size:12.0pt\">Clofazimine</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It has a weak <strong>bactericidal</strong> activity against <strong>mycobacterium leprae </strong>&amp; causes <strong>deposition</strong> of crystals in <strong>intestinal mucosa, liver, lymph nodes </strong>&amp;<strong> spleen.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other <strong>adverse effects</strong> of Clofazimine are:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Icthyosis </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">of skin.</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skin <strong>discoloration</strong> (red to purple black)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lepromin test</strong> is used to <strong>assess</strong> the <strong>type</strong> of <strong>immune response</strong> in <strong>leprosy</strong> and is not a diagnostic test, while <strong>Multi Drug Therapy</strong> for <strong>12 months</strong>, the mechanism of action of <strong>dapsone</strong>, and the side effects of <strong>clofazimine</strong> are important <strong>aspects</strong> of <strong>leprosy management.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Rooks Textbook of Dermatology 9<sup>th</sup> Edition Chapter 28 Page No. 28.1- 28.15</span></strong></span></span></p>",
    "correct_choice_id": 67662,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 16927,
    "choices": [
      {
        "id": 67668,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Type 1 Lepra Reaction presents with new Red Painful Lesions</span></span></span></p>"
      },
      {
        "id": 67669,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Systemic Symptoms are a feature of Type 2 Lepra Reaction</span></span></span></p>"
      },
      {
        "id": 67670,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Type 2 Lepra Reaction is due to Immune Complex Deposition</span></span></span></p>"
      },
      {
        "id": 67671,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Steroids are Drug of Choice in both Type 1 &amp; 2 Lepra Reactions</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All of the following are correct statements regarding Reactions in leprosy EXCEPT:</span></span></span></p>",
    "unique_key": "Q9736630",
    "question_audio": null,
    "question_video": null,
    "map_id": 16488,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A) Type 1 Lepra Reaction presents with New Red Painful Lesions</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 2</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> lepra reaction is associated with <strong>Type III</strong> hypersensitivity reaction (<strong>Immune complex</strong> deposition) &amp; clinically it presents with <strong>new </strong>red painful lesions, and also <strong>systemic </strong>features like <strong>fever, arthralgias, anorexia, keratitis, iritis, nephritis, synovitis, orchitis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/picture3.jpg\" style=\"height:564px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/2.jpg\" style=\"height:198px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/3.jpg\" style=\"height:207px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/picture5.jpg\" style=\"height:563px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In leprosy, <strong>Type 1 reactions</strong> involve <strong>inflammation</strong> of <strong>existing lesions</strong> rather than the appearance of new lesions, while <strong>Type 2 reactions</strong> may present with <strong>systemic symptoms</strong> and are related to <strong>immune complex</strong> deposition, with <strong>steroids</strong> being the <strong>treatment of choice</strong> for <strong>both types of reactions</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Rooks Textbook of Dermatology 9<sup>th</sup> Edition Chapter 28 Page No. 28.1- 28.16</span></strong></span></span></p>",
    "correct_choice_id": 67668,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 35872,
    "choices": [
      {
        "id": 143283,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">1, 2</span></p>"
      },
      {
        "id": 143284,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
      },
      {
        "id": 143285,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
      },
      {
        "id": 143286,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which diagnostic investigation is utilized to identify the condition characterized by a 40-year-old man displaying abrupt Erythematous Painful Lesions on the Trunk and Face, Joint Pain, and Glove and Stock Anesthesia?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">1. Nerve examination</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">2. Skin biopsy</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">3. Slit skin smear</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">4. Mantoux test</span></p>",
    "unique_key": "Q7509309",
    "question_audio": null,
    "question_video": null,
    "map_id": 23070,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1, 2, 3</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The clinical scenario points to a case of <strong>leprosy</strong>. The diagnosis of this condition requires <strong>nerve examination, skin biopsy, </strong>and <strong>a slit skin smear</strong> (Option B - 1, 2, 3).</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The clinical presentation described suggests a condition called <strong>leprosy</strong> or <strong>Hansen's</strong> disease, which can cause <strong>skin lesions</strong>, <strong>nerve</strong> damage resulting in <strong>anaesthesia</strong>, and <strong>joint pain</strong>.</span></p></li></ul><ol><li><p style=\"margin-left:40px;text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Nerve examination</strong> - An essential part of the diagnosis of leprosy involves the <strong>examination</strong> of <strong>nerves</strong> for <strong>enlargement</strong> and <strong>tenderness</strong>, which can indicate <strong>nerve damage</strong> due to the disease.</span></p></li><li><p style=\"margin-left:40px;text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Skin biopsy</strong> - A biopsy of the <strong>affected skin</strong> can be taken and <strong>histologically</strong> examined for the presence of <strong>Mycobacterium leprae</strong>, the bacterium that causes <strong>leprosy</strong>.</span></p></li><li><p style=\"margin-left:40px;text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Slit skin smear</strong> - This test involves taking a sample from the skin (usually from the <strong>ear lobes</strong> or from lesions) and staining it for <strong>acid</strong>-<strong>fast bacilli</strong>, which is a characteristic of <strong>Mycobacterium leprae</strong>.</span></p></li></ol><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>The Mantoux Test</strong> (Option 4)</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>Mantoux</strong> test is used to diagnose <strong>tuberculosis</strong>, not leprosy.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">It involves the <strong>Tuberculin Skin Test</strong> (<strong>TST</strong>) to detect Mycobacterium <strong>Tuberculosis</strong> Infection.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Mycobacterium Tuberculosis and Mycobacterium Leprae are <strong>both acid</strong>-<strong>fast</strong> Bacilli.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The Mantoux test is <strong>specific</strong> for <strong>TB</strong> and does <strong>not</strong> directly <strong>aid</strong> in the <strong>diagnosis</strong> of <strong>leprosy</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Characteristic clinical features of <strong>Hansen\u2019s Disease</strong> / <strong>Leprosy</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Mycobacterium leprae </strong>is the cause of the<strong> chronic granulomatous disease </strong>known as<strong> leprosy</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> typical incubation period </strong>for<strong> leprosy </strong>is<strong> 2 to 12 years.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">It frequently manifests as a <strong>visible skin</strong> lesion, such as a <strong>hypopigmented</strong> or <strong>erythematous</strong> macule, or as a <strong>numb spot</strong> on the <strong>skin</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>face, buttocks, trunk, </strong>and<strong> extensor aspects</strong> of the limbs are frequently <strong>affected</strong> by <strong>lesions</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Skin, cutaneous, </strong>and<strong> peripheral nerves</strong>, as well as <strong>mucous</strong> <strong>membranes</strong>, are all <strong>impacted</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The Ulnar nerve followed by the <strong>posterior tibial nerve</strong>, median and <strong>lateral popliteal nerves</strong>, are the <strong>peripheral nerves</strong> that are most frequently <strong>affected</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> facial nerve </strong>is the<strong> cranial nerve </strong>that is involved<strong> most frequently.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Both <strong>nerve function</strong> and <strong>hair growth</strong> are <strong>compromised</strong> by the <strong>lesions</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Burns </strong>or<strong> ulcers </strong>on the<strong> amputation limb </strong>may also be<strong> present </strong>in the<strong> patients.</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Classification Systems of Leprosy:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ridley-Jopling Classification</strong></span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Tuberculoid (TT)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Borderline tubercular (BT)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Borderline (BB)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Borderline lepromatous (BL)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Lepromatous (LL)</span></p></li></ul></li></ul><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>WHO Classification:</strong></span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Paucibacillary</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Multibacillary</span></p></li></ul></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Cardinal Signs </strong>for the<strong> Diagnosis </strong>of<strong> Leprosy:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/screenshot-2024-02-22-094332.jpg\" alt=\"\" width=\"1000\" height=\"306\"></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>presence</strong> of <strong>two</strong> of the <strong>three signs</strong> can establish the diagnosis of <strong>leprosy</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Other tests done for <strong>diagnosis</strong> of <strong>leprosy</strong> include <strong>nerve biopsy </strong>in<strong> pure neural leprosy </strong>and<strong> PGL-1 antibody </strong>in cases with<strong> low bacterial load</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Mantoux test </strong>is<strong> not </strong>useful<strong> </strong>in<strong> diagnosis </strong>of<strong> leprosy</strong>. This is the test which helps to explain the <strong>prognosis </strong>of leprosy.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The appropriate diagnostic investigations for a <strong>suspected case</strong> of <strong>leprosy</strong> include <strong>nerve</strong> examination, skin <strong>biopsy</strong>, and <strong>slit skin smear</strong> to detect the <strong>presence</strong> of <strong>Mycobacterium leprae</strong> and to <strong>assess</strong> the <strong>extent</strong> of <strong>nerve damage</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref:</u> Rooks Textbook of Dermatology- 9<sup>th</sup> Edition Chapter 28 Page No 28.1, 28.3, 28.12</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Harrisons Principles of Internal Medicine, 21<sup>st</sup> Edition 1385, 1386, 1388</strong></span></p>",
    "correct_choice_id": 143284,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 35875,
    "choices": [
      {
        "id": 143295,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stop MDT and Start Oral Steroids</span></span></span></p>"
      },
      {
        "id": 143296,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antibiotics</span></span></span></p>"
      },
      {
        "id": 143297,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thalidomide</span></span></span></p>"
      },
      {
        "id": 143298,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continue MDT and Add Oral Steroids</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In a pregnant woman at 12 weeks of gestation, who is currently undergoing multidrug therapy (MDT) for leprosy, she now presents with type 2 lepra reaction. What is the preferred treatment for this patient?</span></span></span></p>",
    "unique_key": "Q7134361",
    "question_audio": null,
    "question_video": null,
    "map_id": 23071,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Continue MDT and Add Oral Steroids</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the management of leprosy, it is crucial to <strong>continue M</strong><strong>ulti Drug Therapy</strong> <strong>(MDT) </strong>to effectively treat the <strong>underlying infection </strong>caused by <strong>Mycobacterium Leprae.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>Type 2 lepra </strong>reaction, also known as <strong>Erythema Nodosum Leprosum (ENL), </strong>is a complex <strong>immunological reaction </strong>that occurs in <strong>Lepromatous and Borderline Lepromatous Leprosy</strong>, which can present with <strong>Painful Nodules</strong>, <strong>Fever, Malaise</strong>, and other <strong>Systemic </strong>symptoms.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral Steroids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, such as <strong>Prednisone</strong>, are the treatment of choice for controlling <strong>Acute Inflammatory Complications </strong>associated with Type 2 Lepra Reaction. They help <strong>Reduce Inflammation </strong>and <strong>Immune</strong> response.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is important to manage the reaction <strong>without discontinuing </strong>the <strong>MDT</strong> to <strong>prevent </strong>the development of <strong>Drug Resistance </strong>and further progression of the disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Erythema Nodosum Leprosum (ENL)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a <strong>type 3 hypersensitive immune complex-mediated reaction</strong> that affects the <strong>skin, nerves, and other organs. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is typically r<strong>ecurrent</strong> and commonly observed in individuals with <strong>multibacillary</strong> leprosy. ENL may occur <strong>before treatment</strong>, <strong>during treatment</strong> or <strong>after</strong> completion of treatment.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by <strong>painful, erythematous nodules</strong> appearing on the extensor surfaces of the <strong>limbs and face.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a type 2 lepra reaction, <strong>systemic symptoms </strong>such as <strong>iritis, orchitis</strong>, and the appearance of <strong>fresh </strong>skin lesions can be observed.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Treatment includes:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High doses of <strong>glucocorticoids</strong> are frequently administered to all patients which assist in <strong>reducing</strong> the acute signs and symptoms of <strong>inflammation.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with lepra reactions, <strong>MDT is never discontinued</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only severe cases of type-2 lepra reaction or erythema nodosum Leprosum are treated with thalidomide.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Thalidomide is <strong>gold standard for type II Lepra</strong> reaction, but it is <strong>NOT the Drug of Choice</strong> due to its <strong>cost</strong> factor &amp; also its <strong>Adverse drug reactions profile.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Type I &amp; II Lepra Reactions (ENL= Erythema Nodosum Leprosum): </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/screenshot-2024-02-22-094524.jpg\" style=\"height:406px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To manage a <strong>pregnant woman </strong>experiencing a <strong>type 2 lepra reaction</strong>, it is essential to <strong>continue the multidrug therapy (MDT)</strong> while adding <strong>oral steroids </strong>as an <strong>additional</strong> treatment.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">Stop MDT and start oral steroids:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stopping MDT is <strong>not advisable</strong> because it can lead to the <strong>proliferation</strong> of <strong>Mycobacterium leprae</strong> and risk the development of <strong>drug resistance.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><span style=\"font-size:12.0pt\">Antibiotics:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>antibiotics</strong> are a <strong>part of MDT</strong> to treat the <strong>bacterial infection</strong>, they alone are <strong>not sufficient</strong> to address the <strong>acute inflammatory symptoms</strong> of a Type 2 lepra reaction.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><span style=\"font-size:12.0pt\">Thalidomide<strong>:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalidomide is an <strong>effective treatment</strong> for <strong>Type 2 lepra reactions</strong> due to its <strong>potent anti-inflammatory</strong> properties.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">However, it is <strong>absolutely contraindicated</strong> in <strong>pregnant</strong> <strong>women</strong> due to its <strong>teratogenic effects</strong>, which can cause <strong>severe birth defects as seen in the below image</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/4.jpg\" style=\"height:545px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Phocomelia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a <strong>pregnant</strong> <strong>woman</strong> with <strong>leprosy</strong> who presents with a <strong>Type 2 lepra</strong> reaction, the preferred treatment is to <strong>continue multidrug therapy</strong> and <strong>add oral steroids</strong> to manage the <strong>acute inflammatory symptoms</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalidomide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is c<strong>ontraindicated</strong> in pregnancy due to its <strong>teratogenicity.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">:&nbsp; Rook&#39;s Textbook of Dermatology -9th Edition Chapter 28 Page No 28.16</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Harrison&rsquo;s Principles of Internal Medicine 21<sup>st</sup> Edition Page No 1387, 1390</span></span></strong></p>",
    "correct_choice_id": 143298,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 35880,
    "choices": [
      {
        "id": 143315,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stop MDT give Thalidomide</span></span></span></p>"
      },
      {
        "id": 143316,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continue MDT, Start Thalidomide</span></span></span></p>"
      },
      {
        "id": 143317,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stop MDT, Start Systemic Corticosteroids</span></span></span></p>"
      },
      {
        "id": 143318,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continue MDT, Start Systemic Steroids</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In a case where a patient undergoing Multi-Drug Therapy (MDT) experiences a deterioration of existing lesions and nerve complications, what course of action would you consider taking next?</span></span></span></p>",
    "unique_key": "Q6327792",
    "question_audio": null,
    "question_video": null,
    "map_id": 23072,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">D) Continue MDT, Start Systemic Steroids</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><strong><span style=\"font-size:12.0pt\"> D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is the <strong>correct management</strong> for a leprosy patient with <strong>nerve damage</strong>, which is likely due to an <strong>immune reaction</strong> called a <strong>leprosy reaction</strong>. <strong>Systemic corticosteroids</strong> are used to control the <strong>inflammation</strong> and <strong>prevent</strong> further <strong>nerve damage</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MDT should be continued to <strong>treat</strong> the <strong>underlying infection</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The reason for selecting option D is that <strong>systemic corticosteroids</strong> are <strong>effective</strong> in treating <strong>acute nerve inflammation</strong> and can prevent <strong>further damage</strong> while <strong>continuing MDT </strong>ensures that the infection<strong> </strong>is<strong> adequately treated.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The situation described, where <strong>pre-existing lesions worsen </strong>during<strong> multi-drug therapy (MDT) </strong>for<strong> leprosy, indicates </strong>a<strong> type 1 lepra reaction</strong>. In managing this condition, the recommended approach would be to <strong>continue MDT while initiating systemic steroid treatment.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 1 lepra reactions are marked by inflammation of existing skin lesions, <strong>leading to symptoms such as edema, redness, and pain.</strong> While <strong>ulcers</strong> are <strong>uncommon</strong>, the development of new lesions is <strong>exceptionally rare</strong>. Additionally, <strong>acute neuritis</strong> may occur, presenting with <strong>tenderness</strong> and <strong>impairment</strong> of <strong>both motor</strong> and <strong>sensory functions</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with<strong> lepra reactions, MDT </strong>is<strong> never discontinued</strong></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>NSAIDs</strong> and <strong>oral steroids</strong> can be added to treat pain.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalidomide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is considered the <strong>gold standard</strong> for treating severe cases of <strong>type-2 lepra reaction</strong> or <strong>erythema nodosum leprosum</strong>. However, it is <strong>not the Drug of Choice</strong> due to its <strong>high cost</strong> and <strong>potential</strong> for <strong>adverse drug reactions</strong>. In<strong> type II lepra reactions, </strong>patients may<strong> </strong>experience<strong> systemic symptoms </strong>such as<strong> iritis, orchitis</strong>,<strong> </strong>and<strong> the </strong>appearance of new<strong> skin lesions.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Type I &amp; II Lepra Reactions:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/screenshot-2024-02-22-094555.jpg\" style=\"height:309px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">(ENL = Erythema Nodosum Leprosum)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">Stop MDT give thalidomide.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalidomide is an <strong>immunomodulatory</strong> drug that may be used in certain conditions, like <strong>leprosy</strong> and its complications. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">However, <strong>stopping MDT is not recommended</strong> as it is crucial to continue the treatment of the primary disease. Thalidomide is <strong>not used as </strong>treatment for <strong>Type 1 lepra reaction in leprosy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><span style=\"font-size:12.0pt\">Continue MDT, start thalidomide &ndash;<strong> </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While MDT should be continued, thalidomide is not typically used for nerve complications. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It&#39;s used <strong>primarily</strong> for severe or recurrent <strong>erythema nodosum leprosum (ENL) Type 2 Lepra eaction,</strong> which is an immune-mediated complication of leprosy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><span style=\"font-size:12.0pt\">Stop MDT, start systemic corticosteroids</span><span style=\"font-size:12.0pt\"> &ndash; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stopping MDT is not advised as the antibiotics in MDT are essential for <strong>treating</strong> the <strong>bacterial infection</strong> causing the <strong>disease</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The MDT should be continued to <strong>prevent</strong> the <strong>development</strong> of <strong>drug resistance</strong> and to <strong>adequately treat</strong> the <strong>underlying infection</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the case of <strong>nerve complications </strong>in a patient undergoing <strong>multi-drug therapy </strong>for conditions like <strong>leprosy</strong>, the appropriate course of action is to <strong>continue the anti-microbial therapy</strong> and start <strong>systemic steroids </strong>to manage the <strong>inflammatory</strong> reaction causing nerve damage.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rook&#39;s Textbook of Dermatology -9th Edition Chapter 28 Page No 28.5, 28.12, 28.16</span></span></strong></p>",
    "correct_choice_id": 143318,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 35884,
    "choices": [
      {
        "id": 143331,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Packet 1 for 12 Months</span></p>"
      },
      {
        "id": 143332,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Packet 2 for 12 Months</span></p>"
      },
      {
        "id": 143333,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Packet 1 for 6 Months</span></p>"
      },
      {
        "id": 143334,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Packet 2 for 6 Months</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old patient presents to the outpatient department with a satellite skin lesion. On examination, the patient has one hypopigmented lesion and one thickened nerve. The images of two blister packs are provided. Based on the WHO / NLEP Guidelines, which treatment is most appropriate for this patient?</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_q7gUPBV.jpeg\" alt=\"A close-up of a packet\r\n\r\n\r\n\r\nDescription automatically generated\" width=\"243\" height=\"174\"></p>",
    "unique_key": "Q3085843",
    "question_audio": null,
    "question_video": null,
    "map_id": 23073,
    "difficulty_level": "difficult",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:10.5pt;\">The correct answer is <strong>B. Packet 2 for 12 months</strong>.</span></p><h3><span style=\"color:#1F3763;font-size:10.5pt;\">Explanation:</span></h3><p><span style=\"font-size:13.5pt;\"><strong>Latest Guidelines for Leprosy: NLEP = WHO (from April 1, 2025)</strong></span></p><p>As of <strong>April 1, 2025</strong>, <strong>India's NLEP has aligned completely with WHO guidelines</strong> for the <strong>diagnosis and treatment of leprosy</strong>. This means that the <strong>same criteria and drug regimens</strong> are now followed globally and in India.</p><p>&nbsp;</p><figure class=\"table\"><table><tbody><tr><td style=\"background-color:#4472C4;border:1.0pt solid #4472C4;height:21.0pt;padding:.75pt;width:494.25pt;\" colspan=\"3\"><span style=\"color:white;font-size:9.0pt;\"><strong>World health organization (WHO)&nbsp;</strong></span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:28.5pt;padding:.75pt;width:288.75pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Cardinal features</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:105.0pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Paucibacillary&nbsp;</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:100.5pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Multibacillary&nbsp;</strong></span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:35.25pt;padding:.75pt;width:288.75pt;\"><span style=\"font-size:9.0pt;\"><strong>Skin: Hypopigmented/ Hypoanesthetic patches</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:105.0pt;\"><span style=\"font-size:9.0pt;\">1-5&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:100.5pt;\"><span style=\"font-size:9.0pt;\">\u22656</span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:34.5pt;padding:.75pt;width:288.75pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Nerves thickened +/- tenderness</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:105.0pt;\"><span style=\"color:black;font-size:9.0pt;\">No&nbsp;</span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:100.5pt;\"><span style=\"color:black;font-size:9.0pt;\">\u22651&nbsp;</span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:20.25pt;padding:.75pt;width:288.75pt;\"><span style=\"font-size:9.0pt;\"><strong>SSS AFB</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:105.0pt;\"><span style=\"font-size:9.0pt;\">Absent&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:100.5pt;\"><span style=\"font-size:9.0pt;\">Present&nbsp;</span></td></tr></tbody></table></figure><p><span style=\"font-size:10.5pt;\"><i>*If a case has any one of the three features suggestive of MB, he/she is classified as MB.</i></span></p><p>&nbsp;</p><p><span style=\"font-size:13.5pt;\"><strong>Treatment Regimen: WHO &amp; NLEP (Post April 1st 2025)</strong></span></p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TvF6QJv.png\" alt=\"A chart of medication\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\nDescription automatically generated with medium confidence\" width=\"337\" height=\"173\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_lvloMqq.png\" alt=\"Health &amp; Family Welfare Department, Government of Tamil Nadu\" width=\"184\" height=\"239\"></p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_LCh7rB3.png\" width=\"463\" height=\"250\"></span></p><p>&nbsp;</p><p>&nbsp;</p><h3><span style=\"color:#1F3763;font-size:10.5pt;\">Other Options:</span></h3><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option A: Packet 1 for 12 months:</strong>&nbsp;</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">This packet was used for the treatment of paucibacillary leprosy according to old guidelines of NLEP, which is not suitable for a patient with multibacillary leprosy.</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option C: Packet 1 for 6 months:&nbsp;</strong></span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">This packet was used for the treatment of paucibacillary leprosy according to old guidelines of NLEP, which is not suitable for a patient with multibacillary leprosy.</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option D Packet 2 for 6 months:</strong>&nbsp;</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">Although Packet 2 contains the correct medications, the treatment duration of 6 months is insufficient for multibacillary leprosy according to WHO guidelines, which recommends 12 months.</span></p><p>&nbsp;</p><p>OLD NLEP GUIDELINES to diagnose Leprosy&nbsp;</p><figure class=\"table\"><table><tbody><tr><td style=\"background-color:#4472C4;border:1.0pt solid #4472C4;height:21.0pt;padding:.75pt;width:469.5pt;\" colspan=\"3\"><span style=\"color:white;font-size:9.0pt;\"><strong>National Leprosy Eradication Programme (NLEP)&nbsp;</strong></span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:28.5pt;padding:.75pt;width:281.9pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Cardinal features</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:91.3pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Paucibacillary&nbsp;</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:96.3pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Multibacillary&nbsp;</strong></span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:35.25pt;padding:.75pt;width:281.9pt;\"><span style=\"font-size:9.0pt;\"><strong>Skin: Hypopigmented/ Hypoanesthetic patches</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:91.3pt;\"><span style=\"font-size:9.0pt;\">1-5&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:96.3pt;\"><span style=\"font-size:9.0pt;\">\u22656</span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:34.5pt;padding:.75pt;width:281.9pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Nerves thickened +/- tenderness</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:91.3pt;\"><span style=\"color:black;font-size:9.0pt;\">No or 1 nerve</span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:96.3pt;\"><span style=\"color:black;font-size:9.0pt;\">&gt;1&nbsp;</span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:20.25pt;padding:.75pt;width:281.9pt;\"><span style=\"font-size:9.0pt;\"><strong>SSS AFB</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:91.3pt;\"><span style=\"font-size:9.0pt;\">Absent&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:96.3pt;\"><span style=\"font-size:9.0pt;\">Present&nbsp;</span></td></tr></tbody></table></figure><p>&nbsp;</p><p>OLD NLEP GUIDELINES to treat Leprosy&nbsp;</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XtDaahO.png\" alt=\"A chart of drugs and drugs\r\n\r\nAI-generated content may be incorrect.\" width=\"468\" height=\"243\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_oiKCOxp.png\" alt=\"A green label with black circles and white text\r\n\r\nAI-generated content may be incorrect.\" width=\"468\" height=\"257\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_EcNy2Kg.png\" alt=\"A close-up of pills\r\n\r\nAI-generated content may be incorrect.\" width=\"416\" height=\"229\"></p><p><span style=\"font-size:10.5pt;\"><i><strong>Educational objective:</strong></i></span></p><ul style=\"list-style-type:disc;\"><li>As of <strong>April 1, 2025</strong>, <strong>NLEP follows WHO guidelines</strong> for both <strong>diagnosis and treatment</strong>.</li><li>Classification is based on <strong>skin lesions</strong>, <strong>nerve involvement</strong>, and <strong>skin smear</strong>.</li><li><span style=\"font-size:10.5pt;\">For a patient with <i><strong>multibacillary leprosy</strong></i>, characterized by <i><strong>one or more thickened nerves</strong></i> and <i><strong>multiple skin lesions</strong></i>, the appropriate treatment is with a regimen containing <i><strong>rifampicin, clofazimine, and dapsone (Packet 2)</strong></i> for a duration of <i><strong>12 months.</strong></i></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><strong>References:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>Jopling\u2019s handbook of leprosy, 6<sup>th</sup> edition, page no 10</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>Andrew\u2019s diseases of the skin: clinical dermatology 13<sup>th</sup> edition page no 338, 339, 345</strong></span></p>",
    "correct_choice_id": 143332,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 35886,
    "choices": [
      {
        "id": 143339,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 2, 4</span></span></span></p>"
      },
      {
        "id": 143340,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 3, 4</span></span></span></p>"
      },
      {
        "id": 143341,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2, 3, 4</span></span></span></p>"
      },
      {
        "id": 143342,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 2, 3</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemoprophylaxis for Leprosy should be given to which of the following persons?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sharing the Same Clothes, Towels</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Living with a patient with Leprosy for &gt; 6 Month</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Contact of Age more than 2 Years</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Contact for more than 20 Hours per Week.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>",
    "unique_key": "Q8212684",
    "question_audio": null,
    "question_video": null,
    "map_id": 23074,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) 2, 3, 4</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemoprophylaxis for leprosy should be given to contacts 2, 3 and 4.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chemoprophylaxis for leprosy should be given to the following contacts:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Being identified as a contact, i.e., a person who has been in <strong>close contact</strong> with the index case for <strong>20 hours (</strong>option 4<strong>) </strong>or<strong> more per week </strong>for<strong> more than 3 months (Option 2)</strong> (Exception is <strong>blanket approach</strong> where no link with an index case needs to be established.)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age: More than 2 years (Option 3);</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> if <strong>younger than 2 years</strong>, the child can be given <strong>SDR</strong> at the <strong>age</strong> of <strong>2</strong>, in <strong>follow-up visits</strong> of <strong>contacts</strong> (if meeting all other inclusion criteria.) </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Consent of the contact obtained</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Depending on the country situation, this can be <strong>written</strong> or <strong>verbal consent</strong>. In the case of children, consent should be obtained from the <strong>parent</strong> or <strong>guardian,</strong> and sometimes an <strong>assent</strong> from the <strong>grown-up children.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sharing</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> the same <strong>clothes and towels,</strong> while a potential <strong>route of transmission</strong>, is <strong>not</strong> generally considered a primary <strong>criterion</strong> for <strong>chemoprophylaxis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong style=\"font-family:Calibri,sans-serif; font-size:11pt\"><span style=\"font-size:12.0pt\">Rifampicin:</span></strong></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>single dose of 600 mg</strong> kills more than <strong>99%</strong> of the <strong>susceptible organisms</strong> present at the start of treatment, that is as much as <strong>3 to 6 months</strong> of daily treatment with the combination <strong>dapsone plus Clofazimine.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampicin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> has become established as a <strong>highly potent bactericidal drug</strong>, and it acts by <strong>inhibiting</strong> the <strong>bacterial DNA dependent RNA polymerase</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Single Dose of Rifampicin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (SDR) is used in <strong>chemoprophylaxis. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemoprophylaxis must be initiated only <strong>4 weeks after treatment for leprosy</strong> has begun in the <strong>patient</strong>to ensure the <strong>patient is non-infectious</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/screenshot-2024-02-22-094813.jpg\" style=\"height:308px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><u><strong>Educational Objective&nbsp;</strong></u></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Exclusion Criteria</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persons with possible signs and/or symptoms of <strong>Leprosy.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persons with possible signs and/or symptoms of <strong>TB </strong>or<strong> Confirmed </strong>with<strong> TB.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persons with a history of <strong>Liver </strong>or<strong> Kidney Disorders</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pregnancy</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">; SDR can be <strong>given after the delivery</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persons who have received <strong>Rifampicin </strong>in the<strong> last two years</strong> e.g. as treatment of TB, leprosy or as prophylaxis (e.g. contact of another index case).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persons with history of <strong>Allergy </strong>to<strong> Rifampicin</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Refusal </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">to take<strong> SDR.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><span style=\"font-size:12.0pt\">: <strong>Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page no 242</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Leprosy/Hansen disease: Contact Tracing and Post-Exposure ;Prophylaxis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><a href=\"https://www.who.int/publications/i/item/9789290228073\" style=\"color:#0563c1; text-decoration:underline\">https://www.who.int/publications/i/item/9789290228073</a></span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"> (Page 23, 24)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051288/\" style=\"color:#0563c1; text-decoration:underline\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051288/</a></span></span></span></p>",
    "correct_choice_id": 143341,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 35889,
    "choices": [
      {
        "id": 143351,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1 week </span></span></span></p>"
      },
      {
        "id": 143352,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2 weeks</span></span></span></p>"
      },
      {
        "id": 143353,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3 weeks</span></span></span></p>"
      },
      {
        "id": 143354,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">5 weeks</span></span></span><br />\r\n&nbsp;</p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapsone syndrome in Hansen disease treatment is seen after how many weeks of therapy initiation?</span></span></span></p>",
    "unique_key": "Q8212377",
    "question_audio": null,
    "question_video": null,
    "map_id": 23075,
    "difficulty_level": "difficult",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">D) 5 weeks</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapsone syndrome, also known as <strong>&quot;five-week dermatitis,&quot;</strong> usually occurs <strong>five</strong> to <strong>six weeks</strong> <strong>after</strong> the <strong>initiation</strong> of <strong>dapsone treatment</strong> in <strong>Hansen&#39;s disease (leprosy</strong>). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is characterized by symptoms such as <strong>erythroderma, generalized lymphadenopathy, hepatosplenomegaly, fever, </strong>and<strong> hepatitis</strong>, and typically <strong>subsides</strong> upon <strong>cessation</strong> of the drug.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Dapsone syndrome</strong>, a <strong>hypersensitivity reaction </strong>characterized by a range of symptoms including <strong>erythroderma and hepatosplenomegaly</strong>, typically occurs about <strong>five to six weeks</strong> after the initiation of dapsone therapy in the treatment of Hansen&#39;s disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span></strong><strong><span style=\"font-size:12.0pt\">Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page No 245</span></strong></span></span></p>",
    "correct_choice_id": 143354,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 35892,
    "choices": [
      {
        "id": 143363,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is used to define the Immune Status of the patient. </span></span></span></p>"
      },
      {
        "id": 143364,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is a Diagnostic Test. </span></span></span></p>"
      },
      {
        "id": 143365,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is a Cell-Mediated Response. </span></span></span></p>"
      },
      {
        "id": 143366,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It may be used for Prognosis.</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 40-year-old patient with a suspected case of leprosy undergoes a lepromin skin test. The test is administered to assess the patient&#39;s type of leprosy and potential response to treatment. Which of the following statements is INCORRECT regarding the lepromin test?</span></span></span></p>",
    "unique_key": "Q1375474",
    "question_audio": null,
    "question_video": null,
    "map_id": 23085,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">B) It is a Diagnostic Test</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The lepromin test is <strong>not </strong>used for the<strong> diagnosis</strong> of leprosy, as it does <strong>not differentiate</strong> between those <strong>infected</strong> and those <strong>who are not</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is used primarily for <strong>prognosis</strong> and to determine the <strong>type</strong> of <strong>immune response</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">It is used to define the immune status of the patient</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lepromin test is used to determine the patient&#39;s <strong>immune response</strong> to <strong>Mycobacterium leprae</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A positive test suggests a <strong>good cell-mediated immune</strong> response, typically seen in <strong>tuberculoid leprosy.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><span style=\"font-size:12.0pt\">It is a cell-mediated response</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lepromin test measures a <strong>delayed-type hypersensitivity</strong> reaction, which is a <strong>cell-mediated immune response</strong> to the <strong>antigens</strong> of <strong>Mycobacterium leprae</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><span style=\"font-size:12.0pt\">It may be used for prognosis</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A <strong>positive lepromin test</strong> generally indicates a <strong>better prognosis</strong> and is associated with a <strong>stronger cell-mediated immune</strong> response, which is <strong>typical</strong> of <strong>tuberculoid leprosy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lepromin test is used to assess the <strong>immune status</strong> of a patient with leprosy and is <strong>not a diagnostic</strong> test. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It measures the <strong>cell-mediated immune response</strong> and can provide <strong>prognostic information</strong>, with a <strong>positive test indicating</strong> a <strong>better prognosis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span></strong><strong><span style=\"font-size:12.0pt\">Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page No 11</span></strong></span></span></p>",
    "correct_choice_id": 143364,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 35896,
    "choices": [
      {
        "id": 143379,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Rifampicin 450 mg Clofazimine 150 mg Dapsone 50 mg</span></p>"
      },
      {
        "id": 143380,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Rifampicin 600 mg Clofazimine 300 mg Dapsone 100 mg</span></p>"
      },
      {
        "id": 143381,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Rifampicin 450 mg Clofazimine 150 mg Dapsone 100 mg</span></p>"
      },
      {
        "id": 143382,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Rifampicin 300 mg Clofazimine 150 mg Dapsone 50 mg</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 12-year-old child presented with multiple hypopigmented patches on back &amp; lower limb. On examination the patches were hypo aesthetic &amp; bilateral ulnar and lateral popliteal nerves were enlarged. Which of the following drugs and their dosages are to be given on Day 1 of supervised drug administration according to National Leprosy Eradication Programme (NLEP) Guidelines?</span></p>",
    "unique_key": "Q7282389",
    "question_audio": null,
    "question_video": null,
    "map_id": 23086,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A) Rifampicin 450 mg Clofazimine 150 mg Dapsone 50 mg</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:13.5pt;\"><strong>Latest Guidelines for Leprosy: NLEP = WHO (from April 1, 2025)</strong></span></p><p>As of <strong>April 1, 2025</strong>, <strong>India's NLEP has aligned completely with WHO guidelines</strong> for the <strong>diagnosis and treatment of leprosy</strong>. This means that the <strong>same criteria and drug regimens</strong> are now followed globally and in India.</p><p>&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 12-year-old child presenting with multiple hypopigmented and hypo aesthetic patches with bilateral ulnar and popliteal nerves enlarged clinches the diagnosis of <strong>Multi Bacillary Leprosy</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hence treatment would be with <strong>MB MDT regimen</strong> according to <strong>NLEP Guidelines</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">According to the <strong>National Leprosy Eradication Programme (NLEP) Guidelines</strong>, for a child aged <strong>9-14 years</strong>, the <strong>Day 1</strong> supervised dose of medication for <strong>Multi-Bacillary (MB) leprosy</strong> includes <strong>Rifampicin 450 mg, Clofazimine 150 mg, and Dapsone 50 mg</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"margin-left:48px;text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/picture8.jpg\" alt=\"\" width=\"1000\" height=\"740\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Rifampicin 600 mg Clofazimine 300 mg Dapsone 100 mg</strong>:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Incorrect</strong> because this dosage is for <strong>adults with MB leprosy</strong>, not for children.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The correct dosages of multi-drug therapy for a <strong>child with Multi-Bacillary (MB)</strong> leprosy on <strong>Day 1</strong> of supervised treatment according to <strong>NLEP Guidelines</strong>, which for a child aged <strong>9-14 years</strong> includes <strong>Rifampicin 450 mg, Clofazimine 150 mg, and Dapsone 50 mg</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Jopling\u2019s Handbook of Leprosy 6<sup>th</sup> Edition Page No 252</strong></span></p>",
    "correct_choice_id": 143379,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 35900,
    "choices": [
      {
        "id": 143395,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapsone Hypersensitivity Syndrome </span></span></span></p>"
      },
      {
        "id": 143396,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Erythema Nodosum Leprosum </span></span></span></p>"
      },
      {
        "id": 143397,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Lucio Phenomenon </span></span></span></p>"
      },
      {
        "id": 143398,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reversal Reaction</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient of leprosy on multidrug treatment came to OPD after 5 weeks of treatment with rash over the body. On examination he has high grade fever, jaundice, and an itchy rash all over the body. There was no evidence of any red tender nodules over the extremities or elsewhere over the body. What is the likely diagnosis of this patient? </span></span></span></p>",
    "unique_key": "Q9916926",
    "question_audio": null,
    "question_video": null,
    "map_id": 23092,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">A) Dapsone Hypersensitivity Syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: Dapsone Hypersensitivity Syndrome</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapsone Hypersensitivity syndrome is a <strong>severe idiosyncratic reaction</strong> that typically occurs about <strong>5 weeks</strong> after the initiation of therapy. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It presents with <strong>fever, rash (usually maculopapular), lymphadenopath</strong>y, and systemic symptoms such as <strong>hepatitis</strong>, which may manifest as <strong>jaundice</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is <strong>dose-independent</strong> and requires <strong>immediate cessation of dapsone</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><span style=\"font-size:12.0pt\">Erythema nodosum leprosum (ENL)</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ENL, or <strong>Type II lepra reaction</strong>, presents with <strong>tender red nodules,</strong> systemic involvement like <strong>fever, malais</strong>e, and <strong>enlarged tender nerves</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/7.jpg\" style=\"height:401px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;&nbsp;<img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/8.jpg\" style=\"height:227px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The absence of red tender nodules and nerve tenderness makes ENL less likely in this case.</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><span style=\"font-size:12.0pt\">Lucio phenomenon</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lucio phenomenon is a <strong>rare reaction</strong> seen in <strong>diffuse lepromatous leprosy</strong> presenting with <strong>painful erythematous plaques</strong>, typically on the <strong>extremities</strong>, that can progress to <strong>necrosis and ulceration</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It does not typically present with a generalized itchy rash or jaundice.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><span style=\"font-size:12.0pt\">Reversal reaction (Type I reaction)</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Reversal reaction</span></strong><span style=\"font-size:12.0pt\"> is characterized by the <strong>acute inflammation</strong> of <strong>pre-existing</strong> leprosy <strong>skin lesions</strong> and <strong>nerve enlargement</strong> without systemic symptoms like <strong>fever</strong> or <strong>jaundice.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The pruritic rash and systemic symptoms described are not typical of a reversal reaction.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Dapsone Hypersensitivity syndrome</strong> in a <strong>leprosy patient</strong> who presents with <strong>fever, jaundice</strong>, and a widespread <strong>itchy rash</strong> <strong>without tender nodules</strong> or <strong>nerve enlargement</strong>, approximately <strong>5 weeks</strong> after <strong>starting multidrug therapy</strong>. This serious reaction requires <strong>immediate attention</strong> and <strong>discontinuation of dapsone</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: </span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 30 Page No 442</span></strong></span></span></p>",
    "correct_choice_id": 143395,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 35902,
    "choices": [
      {
        "id": 143403,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3 Drugs are given in the regimen</span></span></span></p>"
      },
      {
        "id": 143404,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Treatment Duration is 18 Months</span></span></span></p>"
      },
      {
        "id": 143405,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Treatment should be Completed in 18 Months</span></span></span></p>"
      },
      {
        "id": 143406,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow up Period is 24 Months</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the INCORRECT statement regarding Treatment of a Multi Bacillary Leprosy patient?</span></span></p>",
    "unique_key": "Q3741730",
    "question_audio": null,
    "question_video": null,
    "map_id": 23093,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Treatment Duration is 18 Months</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to the updated guidelines by the <strong>National Leprosy Eradication Programme (NLEP)</strong>, which recommend a treatment duration of <strong>12 months</strong> for <strong>multi-bacillary leprosy</strong>, not 18 months.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">3 drugs are given in the regimen</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>Standard Multi-Drug Therapy (MDT) regimen</strong> for <strong>multi-bacillary (MB) leprosy</strong> involves a <strong>combination</strong> of <strong>three drugs</strong>: <strong>Rifampicin, Dapsone, </strong>and<strong> Clofazimine</strong>.</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/9.jpg\" style=\"height:251px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Option C. </strong>Treatment should be completed in 18 months: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">NLEP guidelines <strong>stipulate</strong> a <strong>12-month treatment</strong> course for <strong>MB leprosy</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This course can be completed in <strong>18 months</strong>, otherwise patient is termed as <strong>Defaulter</strong></span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><span style=\"font-size:12.0pt\">Follow up period is 24 months</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The follow-up period after the completion of treatment for MB leprosy is typically <strong>24 months</strong> to <strong>monitor</strong> for any <strong>signs of relapse</strong> or <strong>late reactions.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>treatment duration</strong> for <strong>multi-bacillary leprosy</strong> according to <strong>NLEP</strong> guidelines is <strong>12 months,</strong> not 18 months, with a <strong>follow-up period</strong> of <strong>24 months post-treatment</strong> to ensure there are <strong>no</strong> <strong>relapses</strong> or <strong>complications</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span></strong><strong><span style=\"font-size:12.0pt\">Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page No 252</span></strong></span></span></p>",
    "correct_choice_id": 143404,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 35904,
    "choices": [
      {
        "id": 143411,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Borderline Lepromatous (BL) </span></span></span></p>"
      },
      {
        "id": 143412,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lepromatous Leprosy (LL) </span></span></span></p>"
      },
      {
        "id": 143413,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pure Neuritic Leprosy </span></span></span></p>"
      },
      {
        "id": 143414,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Borderline (BB)</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Foam Cells are seen in Abundance in which type of Leprosy?</span></span></span></p>",
    "unique_key": "Q1497299",
    "question_audio": null,
    "question_video": null,
    "map_id": 23094,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">B) Lepromatous leprosy (LL)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lepromatous leprosy is characterized by numerous <strong>foam cells</strong>, also known as <strong>Virchow&#39;s cells</strong>, which are <strong>lipid-laden macrophages</strong> filled with <strong>Mycobacterium leprae.</strong></span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/10_oTthCEA.jpg\" style=\"height:289px; width:400px\" /></p>\r\n\r\n<p style=\"margin-left:24px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">Borderline lepromatous (BL<strong>): </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">BL leprosy can have <strong>foam cells</strong>, they are <strong>most abundant</strong> in <strong>LL leprosy</strong> where there is <strong>widespread infiltration</strong> of the <strong>skin</strong> with <strong>numerous bacilli</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><span style=\"font-size:12.0pt\">Pure Neuritic Leprosy:<strong> </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pure Neuritic Leprosy primarily <strong>affects nerves</strong>, and <strong>foam cells</strong> are more typically associated with <strong>cutaneous lesions.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><span style=\"font-size:12.0pt\">Borderline (BB)</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In BB leprosy, <strong>foam cells</strong> may be present but are not as prominent as in LL leprosy. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BB leprosy has features <strong>between tuberculoid</strong> and <strong>lepromatous leprosy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Lepromatous leprosy (LL)</strong>&nbsp;is the <strong>form</strong> of <strong>Hansen&#39;s disease</strong> most associated with the presence of <strong>abundant foam cells</strong>, which are <strong>macrophages </strong>filled with<strong> undigested M. leprae</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These foam cells are indicative of the <strong>multibacillary form</strong> of the <strong>disease</strong> and are used as a <strong>diagnostic histopathological feature</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span></strong><strong><span style=\"font-size:12.0pt\">Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page No 123</span></strong></span></span></p>",
    "correct_choice_id": 143412,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 35907,
    "choices": [
      {
        "id": 143423,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Steroids</span></span></span></p>"
      },
      {
        "id": 143424,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Azathioprine</span></span></span></p>"
      },
      {
        "id": 143425,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chloroquine</span></span></span></p>"
      },
      {
        "id": 143426,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thalidomide</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following medications is used only for treating patients with Type II Lepra reaction but NOT used in Type I Lepra reaction?</span></span></p>",
    "unique_key": "Q3789175",
    "question_audio": null,
    "question_video": null,
    "map_id": 23095,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">D) Thalidomide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thalidomide is particularly <strong>effective</strong> in treating <strong>Type II lepra reactions</strong>, also known as <strong>Erythema Nodosum Leprosum (ENL)</strong>, due to its <strong>potent Anti-Inflammatory</strong> and immunomodulatory effects. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is not used for Type I reactions, which are managed with <strong>steroids</strong> and other <strong>immunosuppressive agents</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">Steroids</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Steroids are used in the management of <strong>both Type I and Type II lepra</strong> reactions. They are effective in <strong>reducing inflammation </strong>and<strong> immune reactions</strong> in <strong>both types</strong> of <strong>reactions</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><span style=\"font-size:12.0pt\">Azathioprine</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Azathioprine may be used as a <strong>steroid-sparin</strong>g <strong>agent</strong> in the treatment of <strong>both Type I</strong> and <strong>Type II lepra reactions,</strong> although it is not the first-line treatment for either.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><span style=\"font-size:12.0pt\">Chloroquine</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chloroquine, an <strong>antimalarial medication</strong>, has been used in the <strong>treatment</strong> of <strong>Erythema Nodosum Leprosum (ENL)</strong>, which is a <strong>Type II reaction</strong>, but it is also used for <strong>Type I reactions</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Thalidomide</strong> is <strong>uniquely</strong> used for <strong>Type II lepra reactions</strong> (<strong>erythema nodosum leprosum)</strong> and is not indicated for Type I lepra reactions. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Thalidomide&#39;s effectiveness</span></strong><span style=\"font-size:12.0pt\"> is based on its ability to <strong>inhibit TNF-alpha</strong>, a <strong>cytokine</strong> involved in the <strong>inflammatory process</strong> of <strong>ENL</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span></strong><strong><span style=\"font-size:12.0pt\">Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page No 217</span></strong></span></span></p>",
    "correct_choice_id": 143426,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 35909,
    "choices": [
      {
        "id": 143431,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Foam Cells.</span></span></span></p>"
      },
      {
        "id": 143432,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Granulomas</span></span></span></p>"
      },
      {
        "id": 143433,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Caseous Necrosis</span></span></span></p>"
      },
      {
        "id": 143434,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acantholysis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the predominant Histological finding in a patient who has Tuberculoid leprosy?</span></span></span></p>",
    "unique_key": "Q3589580",
    "question_audio": null,
    "question_video": null,
    "map_id": 23096,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">B) Granulomas</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The predominant histopathological finding in <strong>tuberculoid leprosy</strong> is well-formed granulomas.</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/22/11_UZu2bb5.jpg\" style=\"height:241px; width:350px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Granulomas consist of <strong>Lymphocytes</strong>, <strong>Epithelioid cells</strong>, and <strong>Langhan&rsquo;s giant cells</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These granulomas consist of <strong>collections</strong> of <strong>immune cells</strong> that form as a response to the presence of <strong>Mycobacterium leprae</strong>, indicative of a <strong>robust immune response</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">Foam Cells</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Foam cells, or <strong>Virchow&#39;s cells</strong>, are typically found in <strong>lepromatous leprosy,</strong> not tuberculoid leprosy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><span style=\"font-size:12.0pt\">Caseous Necrosis</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Caseous necrosis is a characteristic feature of t<strong>uberculosis</strong>, not leprosy. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In leprosy, especially the tuberculoid form, <strong>granulomas</strong> are predominantly seen and <strong>caseous necrosis</strong> is only seen with <strong>Nerve granulomas.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><span style=\"font-size:12.0pt\">Acantholysis</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acantholysis refers to the <strong>loss of connections</strong> between <strong>keratinocytes</strong> in the <strong>epidermis</strong> and is seen in conditions such as <strong>pemphigus vulgaris</strong>, not in leprosy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Granulomas</strong>&nbsp;is the predominant histopathological feature in <strong>tuberculoid leprosy,</strong> reflecting a <strong>strong cell-mediated immune</strong> response that <strong>contains the infection</strong> and <strong>prevents widespread dissemination.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 14 Page No 136</span></strong></span></span></p>",
    "correct_choice_id": 143432,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 35912,
    "choices": [
      {
        "id": 143443,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Seen in Borderline Lepromatous Leprosy and Lepromatous Leprosy patients.</span></span></span></p>"
      },
      {
        "id": 143444,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MDT should be Continued, and Steroids are to be added.</span></span></span></p>"
      },
      {
        "id": 143445,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Underlying Pathogenesis is Increased Cell Mediated Immunity.</span></span></span></p>"
      },
      {
        "id": 143446,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patients present with High Grade Fever, Red Tender Nodules over Body.</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is FALSE in relation to Type 2 Lepra Reaction?</span></span></p>",
    "unique_key": "Q2032284",
    "question_audio": null,
    "question_video": null,
    "map_id": 23097,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Underlying Pathogenesis is Increased Cell Mediated Immunity.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The pathogenesis of <strong>Type 2 Lepra Reaction (ENL</strong>) is primarily due to <strong>immune complex deposition(Type III hypersensitivity reaction</strong>) and not increased <strong>cell-mediated immunity</strong>, which is more characteristic of <strong>Type 1 reactions</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">Seen in Borderline Lepromatous Leprosy and Lepromatous Leprosy patients</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Type 2 Lepra Reaction, also known as <strong>Erythema Nodosum Leprosum (ENL),</strong> is typically seen in patients with <strong>Borderline Lepromatous Leprosy</strong> and <strong>Lepromatous Leprosy</strong>, which are at the <strong>multibacillary end</strong> of the leprosy spectrum.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><span style=\"font-size:12.0pt\">MDT should be continued, and Steroids are to be added</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">During a Type 2 reaction, the mainstay treatment includes the <strong>continuation of Multi-Drug Therapy</strong> (MDT) for leprosy along with the addition of <strong>steroids</strong> to manage the inflammatory reaction.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><span style=\"font-size:12.0pt\">Patients present with High grade fever, Red Tender nodules over body</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical presentation of ENL includes systemic symptoms such as <strong>high-grade fever and red tender nodules</strong>, known as erythema nodosum leprosum.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Type 2 Lepra Reaction (Erythema Nodosum Leprosum</strong>) is associated with <strong>immune complex deposition</strong> rather than <strong>increased cell-mediated immunity</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It presents with <strong>systemic symptoms</strong> and <strong>cutaneous manifestations</strong> requiring the <strong>continuation </strong>of<strong> MDT</strong> and the <strong>addition</strong> of <strong>anti-inflammatory treatment</strong>, typically <strong>steroids.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 29 Page No 424</span></span></strong></p>",
    "correct_choice_id": 143445,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 35914,
    "choices": [
      {
        "id": 143451,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Pure Neuritic</span></span></span></p>"
      },
      {
        "id": 143452,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Borderline Lepromatous</span></span></span></p>"
      },
      {
        "id": 143453,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Borderline Tuberculoid</span></span></span></p>"
      },
      {
        "id": 143454,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Indeterminate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">A 36-year-old male presented multiple hypopigmented patches all over the body which are distributed almost symmetrically. On examination multiple thickened nerves almost symmetrically enlarged are palpable. What type of leprosy does the patient has?</span></span></span></p>",
    "unique_key": "Q9830563",
    "question_audio": null,
    "question_video": null,
    "map_id": 23098,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">B) Borderline Lepromatous</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of <strong>almost symmetrically distributed</strong> <strong>hypopigmented skin patches</strong> over body and </span><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">multiple thickened nerves</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"> almost symmetrically enlarged </span><span style=\"font-size:12.0pt\">suggests <strong>Borderline Lepromatous leprosy.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">Pure Neuritic</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pure Neuritic leprosy presents with <strong>nerve involvement</strong> without the skin lesions, which is not the case in the scenario described.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><span style=\"font-size:12.0pt\">Borderline tuberculoid</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Borderline tuberculoid leprosy would typically present with <strong>fewer </strong>and<strong> asymmetric skin lesions</strong>, and while nerve involvement is common, it does not typically present with symmetry as described.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><span style=\"font-size:12.0pt\">Indeterminate</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Indeterminate leprosy is an <strong>early</strong> and <strong>unstable form</strong>, often presenting as a <strong>single </strong>or a<strong> few hypopigmented macules</strong> without definite nerve enlargement.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Borderline Lepromatous leprosy</strong> as a type <strong>characterized</strong> by <strong>multiple almost symmetrically</strong> distributed <strong>skin lesions</strong> and </span><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">multiple thickened nerves</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"> almost <strong>symmetrically enlarged</strong></span><span style=\"font-size:12.0pt\">.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 15 Page No 244</span></strong></span></span></p>",
    "correct_choice_id": 143452,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette"
    ]
  },
  {
    "id": 35916,
    "choices": [
      {
        "id": 143459,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Teratogenic Drug</span></span></span></p>"
      },
      {
        "id": 143460,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Causes Peripheral Neuropathy</span></span></span></p>"
      },
      {
        "id": 143461,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Useful in Type 2 Lepra Reaction</span></span></span></p>"
      },
      {
        "id": 143462,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Also Useful in Type 1 Lepra Reaction</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Identify the FALSE statement among the following options in relation to Thalidomide in the treatment of leprosy?</span></span></span></p>",
    "unique_key": "Q8929123",
    "question_audio": null,
    "question_video": null,
    "map_id": 23099,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">D) Also Useful in Type 1 Lepra reaction</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thalidomide is not typically used in the treatment of Type 1 Lepra reactions, also known as <strong>reversal reactions</strong>, which are <strong>managed</strong> with <strong>steroids</strong> and other <strong>immunosuppressive therapies</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">Teratogenic drug</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thalidomide is <strong>highly teratogenic</strong> and can cause <strong>severe birth defects</strong>, which is why its use is highly regulated and <strong>contraindicated during pregnancy.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><span style=\"font-size:12.0pt\">Causes Peripheral neuropathy</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A known side effect of thalidomide is <strong>peripheral neuropathy</strong>, which can be a significant complication requiring <strong>monitoring</strong> during treatment.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><span style=\"font-size:12.0pt\">Useful in Type 2 Lepra reaction</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thalidomide is particularly effective in treating <strong>Type 2 Lepra Reactions</strong>, also known as <strong>Erythema Nodosum Leprosum (ENL)</strong>, due to its <strong>Anti-Inflammatory Properties</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Thalidomide</strong> is a <strong>Teratogenic Drug</strong> used in the treatment of <strong>Type 2 Lepra Reactions (Erythema Nodosum</strong> <strong>Leprosum</strong>) and can cause <strong>peripheral neuropathy</strong> as a <strong>side effect</strong>, but it is not used for Type 1 Lepra reactions. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></span></u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 30 Page No 472</span></span></strong></p>",
    "correct_choice_id": 143462,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 35919,
    "choices": [
      {
        "id": 143471,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapsone</span></span></span></p>"
      },
      {
        "id": 143472,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thalidomide</span></span></span></p>"
      },
      {
        "id": 143473,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rifampicin</span></span></span></p>"
      },
      {
        "id": 143474,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clofazimine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which among the following medications can cause orange discolouration of urine?</span></span></span></p>",
    "unique_key": "Q9156899",
    "question_audio": null,
    "question_video": null,
    "map_id": 23100,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">C) Rifampicin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rifampicin can cause <strong>orange-red discoloration</strong> of <strong>bodily fluids</strong>, including <strong>urine, feces, sweat, saliva, </strong>and<strong> tears</strong>. This is a <strong>benign</strong> and <strong>well-recognized side effect</strong> of the <strong>medication</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">Dapsone</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapsone does not typically cause orange discoloration of bodily fluids. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It can cause <strong>hemolysis</strong> and <strong>methemoglobinemia</strong> as <strong>side effects</strong>, especially in patients with <strong>Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><span style=\"font-size:12.0pt\">Thalidomide</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thalidomide does not cause orange discoloration of urine; its significant side effects include <strong>teratogenicity </strong>and <strong>peripheral neuropathy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><span style=\"font-size:12.0pt\">Clofazimine</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clofazimine can cause <strong>skin </strong>and<strong> bodily fluids </strong>to turn<strong> pink </strong>to<strong> brownish black</strong>, but it is not typically associated with orange discoloration of urine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Rifampicin</strong> can cause <strong>orange-red discoloration </strong>of <strong>bodily fluids</strong>, including <strong>urine, </strong>which is a <strong>harmless side effect</strong> and does <strong>not indicate harm</strong> or the need to stop therapy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 30 Page No 442</span></strong></span></span></p>",
    "correct_choice_id": 143473,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 35923,
    "choices": [
      {
        "id": 143487,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tumour Necrosis Factor Alpha (TNF-&alpha;)</span></span></span></p>"
      },
      {
        "id": 143488,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Interferon Gamma (IFN\u2010</span><span style=\"font-size:12.0pt\">&gamma;</span><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">)</span></span></span></p>"
      },
      {
        "id": 143489,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Interleukin 10 (IL-10)</span></span></span></p>"
      },
      {
        "id": 143490,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transforming Growth Factor Beta (TGF&beta;)</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is associated with inflammatory manifestations of Erythema Nodosum Leprosum? </span></span></p>",
    "unique_key": "Q5254854",
    "question_audio": null,
    "question_video": null,
    "map_id": 23101,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">A) Tumour Necrosis Factor Alpha (TNF-&alpha;)</span></strong><span style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TNF-&alpha; is a <strong>cytokine</strong> that plays a key role in the pathogenesis of <strong>Erythema Nodosum Leprosum (ENL), </strong>an <strong>immune-mediated complication</strong> of <strong>leprosy</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">TNF-&alpha;</span></strong><span style=\"font-size:12.0pt\"> is associated with the <strong>inflammatory cascade</strong> that leads to the <strong>formation</strong> of the <strong>painful nodules </strong>characteristic of <strong>ENL</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"> B. Interferon Gamma (IFN\u2010</span></strong><strong><span style=\"font-size:12.0pt\">&gamma;</span></strong><strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">)</span></strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While IFN-&gamma; is a <strong>pro-inflammatory cytokine</strong> involved in the immune response against Mycobacterium leprae, it is not specifically implicated in the pathogenesis of ENL as prominently as TNF-&alpha;.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Interleukin 10 (IL-10)</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IL-10 is an <strong>anti-inflammatory cytokine</strong>, and while it plays a role in the <strong>immune response</strong>, it is not primarily responsible for the inflammatory manifestations seen in ENL.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Transforming growth factor beta (TGF -&beta;)</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TGF-&beta; is generally considered an <strong>anti-inflammatory</strong> and <strong>regulatory cytokine</strong> and is not typically associated with the inflammatory symptoms of ENL.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Tumour Necrosis Factor Alpha (TNF-&alpha;)</strong> is the <strong>cytokine</strong> closely associated with the <strong>inflammatory</strong> manifestations of <strong>Erythema Nodosum Leprosum</strong> in <strong>leprosy</strong>, and management often includes medications that <strong>modulate </strong>the activity of<strong> TNF-&alpha;.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:</span></u></strong><strong> </strong><strong><span style=\"font-size:12.0pt\">Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page No 220</span></strong></span></span></p>",
    "correct_choice_id": 143487,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 35925,
    "choices": [
      {
        "id": 143495,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Isoniazid</span></span></span></p>"
      },
      {
        "id": 143496,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rifampicin</span></span></span></p>"
      },
      {
        "id": 143497,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ethambutol</span></span></span></p>"
      },
      {
        "id": 143498,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ofloxacin </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which among the following is a anti tubercular medication which is also a most potent anti leprotic drug?</span></span></p>",
    "unique_key": "Q8273404",
    "question_audio": null,
    "question_video": null,
    "map_id": 23102,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">B) Rifampicin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rifampicin is not only an important drug for treating <strong>tuberculosis</strong>, but it is also considered the <strong>most potent</strong> anti-leprotic medication. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is an <strong>essential component</strong> of the <strong>Multi-Drug Therapy (MDT)</strong> for <strong>leprosy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">Isoniazid</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While isoniazid is a key component of the <strong>anti-tubercular regimen</strong>, it is not the most potent drug against Mycobacterium leprae, the causative agent of leprosy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><span style=\"font-size:12.0pt\">Ethambutol</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ethambutol is used as part of the treatment for <strong>tuberculosis</strong>, but it does not have the same level of potency against Mycobacterium leprae as rifampicin.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><span style=\"font-size:12.0pt\">Ofloxacin</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ofloxacin is a <strong>fluoroquinolone</strong> antibiotic that can be used in the treatment of <strong>leprosy</strong>, particularly in cases of <strong>drug resistance</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">However, it is <strong>not as potent</strong> as <strong>rifampicin </strong>in the <strong>anti-leprotic regimen</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Rifampicin</strong>&nbsp;is the <strong>most potent anti-leprotic drug </strong>that is also used in the treatment of <strong>tuberculosis</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is a <strong>corner stone</strong> <strong>drug</strong> in the <strong>Multi-Drug Therapy (MDT)</strong> for <strong>leprosy</strong> due to its <strong>bactericidal</strong> action against Mycobacterium leprae.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IAL Textbook of Leprosy, 2<sup>nd</sup> Edition Chapter 31 Page No 449</span></strong></span></span></p>",
    "correct_choice_id": 143496,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 35927,
    "choices": [
      {
        "id": 143503,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rifampicin</span></span></span></p>"
      },
      {
        "id": 143504,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapsone</span></span></span></p>"
      },
      {
        "id": 143505,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clofazimine</span></span></span></p>"
      },
      {
        "id": 143506,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ofloxacin </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which among the following is a anti leprotic drug which is also useful in treatment of Type 2 lepra reaction?</span></span></span></p>",
    "unique_key": "Q5227055",
    "question_audio": null,
    "question_video": null,
    "map_id": 23103,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">C) Clofazimine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clofazimine has <strong>both anti-leprotic </strong>and<strong> anti-inflammatory</strong> properties. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is used in the <strong>treatment</strong> of <strong>leprosy</strong> and has a role in <strong>managing</strong> <strong>Type 2 lepra reactions</strong> due to its <strong>ability</strong> to <strong>reduce inflammation</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">Rifampicin</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While rifampicin is a <strong>potent anti-leprotic drug</strong> used in <strong>multi-drug therapy (MDT)</strong> for leprosy, it is not specifically used for the treatment of Type 2 lepra reaction (Erythema Nodosum Leprosum, ENL).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><span style=\"font-size:12.0pt\">Dapsone</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapsone is an <strong>anti-leprotic drug</strong> used in <strong>MDT</strong> for <strong>leprosy</strong>, but it is not the treatment of choice for Type 2 lepra reactions. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is mainly used for its <strong>antibacterial effects</strong> against Mycobacterium leprae.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><span style=\"font-size:12.0pt\">Ofloxacin</span><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ofloxacin is used as a <strong>second-line agent</strong> for the treatment of <strong>leprosy</strong>, particularly in cases of <strong>drug resistance</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">However, it is not typically used for the treatment of Type 2 lepra reactions.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Clofazimine</strong> is an <strong>anti-leprotic</strong> <strong>medication</strong> that is also <strong>beneficial</strong> in the treatment of <strong>Type 2 lepra</strong> reactions due to its <strong>anti-inflammatory</strong> <strong>effects</strong>, in addition to its role in the <strong>multi-drug therapy</strong> for <strong>leprosy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Jopling&rsquo;s Handbook of Leprosy 6<sup>th</sup> Edition Page No 211</span></span></strong></p>",
    "correct_choice_id": 143505,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  }
];
        let quizName = 'Leprosy';
        let hierarchy = ["Cerebellum", "qBank", "Dermatology"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - QuizMaster Pro';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>